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Cytotoxic T lymphocyte (CTL) mediated killing of infected cells is an indispensable machinery23
of the immune system to remove infected cells from the host body. In vivo imaging of CTL killing24
activity revealed infected cells need multiple contacts with CTLs to die. The impact of increasing25
number of contacts with CTLs on infected cell death remained unexplored.26
In this study, a novel method of analysis called probability of transition analysis (PTA) was27
proposed to study the effect of increasing number of interactions with CTLs on the probability28
of infected cell death. The versatility of the PTA makes it a viable analysis method for various29
systems. The application of PTA on CTL experimental data shows a higher probability of dying30
after multiple contacts with CTLs. The increase in observed probability of killing infected cells at31
each contact suggests a change in behaviour of CTLs or infected cells with increasing number of32
contacts. It is not known whether CTLs become more lethal with increasing contacts with infected33
cells or if infected cells become more susceptible to cell death with increasing number of contacts34
with CTLs.35
To study and discriminate between possible killing mechanisms employed by CTLs, an agent-36
based model was developed. This model accurately mimics the behavior of a lymph node by37
incorporating experimentally observed properties into the system. The model was then used to38
discriminate between proposed hypotheses of CTL mediated killing that could give rise to an39
increase in probability of killing infected cells. The most credible scenario implied an increase in40
susceptibility of infected cells at each CTL contact. However, when allowing T cells to interact with41
already apoptotic target cells (zombie contacts), a contact history independent killing mechanism42
was also in agreement with the experimental datasets. The duration taken by an infected cell to43
die as well as the per capita killing rate (PCKR) were predictive read-outs that could be used to44
differentiate the CTL killing mechanism. The agent-based model and the comparison of observed45
datasets to model data helped us better understand the experimental data by shedding light on46
factors that cannot be measured experimentally.47
We also explored the impact of temporal factors such as variable observation window and48
unknown history by using the agent-based model and PTA. The results indicated a difference that49
arose as a consequence of varying observation time duration and observations initiated at different50






Die durch cytotoxische T-Lymphozyten (CTL) vermittelte Abtötung von infizierten Zellen ist55
ein unverzichtbarer Mechanismus des Immunsystems, um infizierte Zellen aus dem Wirtskörper56
zu entfernen. Durch in vivo-Bildgebung der CTL-Abtötungsaktivität konnte gezeigt werden, dass57
infizierte Zellen mehrere Kontakte mit CTLs benötigen, um abzusterben. Die Auswirkungen eines58
Anstiegs von Kontakten mit CTLs auf den Tod infizierter Zellen sind bisher unerforscht.59
Um die Auswirkung eines solchen Anstiegs von Interaktionen mit CTLs auf die Wahrschein-60
lichkeit des Absterbens infizierter Zellen zu untersuchen, wurde in dieser Studie eine neue Anal-61
ysemethode, die so genannte Übergangswahrscheinlichkeitsanalyse (probability of transition anal-62
ysis, PTA), erprobt. Die Vielseitigkeit der PTA macht sie zu einer praktikablen Analysemethode63
für verschiedene Systeme. Die Anwendung der PTA auf experimentelle CTL-Daten zeigt, dass es64
nach mehrfachen Kontakten mit CTLs eine höhere Sterbenswahrscheinlichkeit gibt.65
Die Zunahme der beobachteten Wahrscheinlichkeit, infizierte Zellen bei jedem einzelnen Kon-66
takt zu töten, lässt auf eine Änderung des Verhaltens von CTLs oder infizierten Zellen mit67
zunehmender Anzahl von Kontakten schließen. Dabei ist nicht bekannt, ob CTLs bei mehr Kon-68
takten mit infizierten Zellen tödlicher werden oder ob infizierte Zellen mit mehr Kontakten mit69
CTLs anfälliger für den Zelltod werden.70
Um mögliche Tötungsmechanismen von CTLs zu untersuchen und zu unterscheiden, wurde ein71
agentenbasiertes Modell entwickelt. Dieses Modell ahmt das Verhalten eines Lymphknotens genau72
nach, indem es experimentell beobachtete Eigenschaften in das System einbezieht.73
Dieses Modell wurde dann zur Unterscheidung zwischen vorgeschlagenen Hypothesen der CTL-74
vermittelten Abtötung verwendet, die zu einer erhöhten Tötungswahrscheinlichkeit infizierter Zellen75
führen könnten. Das zuverlässigste Szenario implizierte eine erhöhte Anfälligkeit der infizierten76
Zellen bei jedem CTL-Kontakt.77
Wenn man jedoch T-Zellen mit bereits apoptotischen Zielzellen (Zombie-Kontakte) interagieren78
lässt, war ein Tötungsmechanimus, der unabhängig von vorherigen Kontakten ist, ebenfalls mit79
experimentellen Datensätzen zu vereinbaren.80
Zwei Messwerte konnten als Prädiktoren zur Differenzierung des CTL-Abtötungsmechanismus81
verwendet werden: Die Dauer, die eine infizierte Zelle zum Absterben benötigte, sowie die Pro-82
Kopf-Abtötungsrate (per capita killing rate, PCKR).83
Das agentenbasierte Modell und der Vergleich von tatsächlich beobachteten Datensätzen mit84
Modelldaten haben uns geholfen, die experimentellen Daten besser zu verstehen, indem sie solche85
Faktoren erklärten, die experimentell nicht gemessen werden können.86
Wir untersuchten auch die Auswirkungen zeitlicher Faktoren wie variable Beobachtungsfenster87
und unbekannte Historien mit Hilfe des agentenbasierten Modells und der PTA. Die Ergebnisse88
wiesen auf einen Unterschied hin, der als Folge der unterschiedlichen Beobachtungszeitdauer und89
der zu verschiedenen Zeitpunkten initiierten Beobachtungen entstand. Das Ergebnis zeigt, wie90
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1.1 Functions of Immune System212
Hundreds of years ago, before Edward Jenner rationalized the immunization process, it was as-213
sumed that diseases were punishments from God or curses from witches. But documentation from214
as early as 430 B.C shows theories that survivors of the Athenian epidemic of typhus and small-pox215
had acquired a partial immunity to the disease [1]. Our knowledge of the immune system is today216
much wider, and we have the chance to have a much clearer picture how the body is protected.217
The immune system, a collection of a multitude of structures, processes and cells, mounts a218
response against harmful foreign substances and diseases within the body to ensure that we do not219
fall sick frequently. The ultimate function of the immune system is to prevent or limit infection,220
and keep the body under homeostasis by removing dead or malignant cells. New immune tasks221
have also been uncovered, for instance the regulation of the metabolic state [2], and also the social222
behavior during sickness [3,4]. Various psychiatric conditions have been correlated with abnormal223
immune responses such as anorexia [5], depression [6], and in the case of obsessive-compulsive224
disorder, a bone marrow transplant has been shown to cure the abnormal behavior in mice [7].225
To combat infections effectively, the immune system detects a wide variety of harmful foreign226
bodies known as pathogens. These pathogens include bacteria and viruses. The immune system227
must distinguish them from the organism’s own healthy cells, and the commensal microbiota from228
the mucosal surfaces like the skin and the gut. Therefore, the decision to attack or tolerate is a229
constant dilemma of immune cells.230
The layers of defense mounted by the immune system can be divided into three distinct groups231
(Figure 1.1).232
1. Physical and chemical barriers: As first line of defense, the surface barriers of the233
body (mucosa) can restrict the entry of pathogens into the body [9], for instance by the234
secretion of antibacterial enzymes by the skin [10], or by tears from the eyes that rinse away235
17
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Figure 1.1: The three layers of the immune system are the physical barriers, innate immune system
and the acquired immune system. Figure reproduced from [8].
pathogens [11]. Additional types of barriers include mucus and cilia that line the nasal236
passages [8] and in the gut mucosal.237
But even in the presence of these barriers, sometimes pathogens can enter the host body. In238
that situation the body requires additional lines of defense.239
2. Innate immunity: The next line of defense of the body is named the innate immune system.240
It is called innate as it recognizes predefined patterns and is less specific to one pathogen241
exclusively i.e. it recognizes broad types of pathogens. It is quick and effective against a242
wide range of pathogens.243
The innate immune system recognizes a type of conserved molecular motifs found in pathogens244
known as pathogen-associated molecular patterns (PAMP) that are essential for pathogen245
survival and hence difficult to modify [12, 13]. The immune receptors to those motifs are246
named pattern recognition receptors (PRRs) [14]. An interaction between PAMPs and PRRs247
initiates a cascade that leads to release of a variety of proinflammatory molecules which to-248
gether coordinate the response to infection [15].249
Apart from these cells, innate immunity has a humoral component which is mediated by250
macromolecules. These include naturally occurring antibodies (NAb), pentraxins and the251
complement and contact cascades [16–18]. These macromolecules are soluble in the plasma252
and are well equipped to mount a strong response against pathogens. These ubiquitous253
innate immune proteins play important roles sensing microbes and initiating pathways to254
ensure removal of the infection.255
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Several molecules playing an important role in the innate immune system are highly con-256
served across plant and animal species implying that it arises from an ancient system that257
existed prior to the divergence between the plant and animal kingdom [19,20]. The different258
cells forming part of the innate immune system are macrophages, mast cell, neutrophils,259
eosinophils, natural killer (NK) cells, dendritic cells, and natural killer T cells [21–27]. These260
cells are involved in processes such as phagocytosis (ingestion of pathogenic fragments, viruses261
or bacteria) and eliciting an inflammatory response. Interestingly, the animal kingdom up262
till invertebrate fish, possess an innate immune system only, showing that innate mechanisms263
are already powerful enough to sustain the survival of such species against infections [28,29].264
3. Adaptive immunity: Despite the efficient functioning of the innate immune system, it is265
complemented by an additional layer of cells and mechanisms known as “adaptive immune266
system”. Especially, in mammals, the innate system is tightly controlled by the adaptive267
system and vice versa, and a lack of adaptive cells like T cells and B cells leads to strong268
immunodeficiencies for people carrying specific mutations [30,31].269
While the innate immune systems mounts a general response against the pathogens, the270
adaptive immune system is highly specific. The adaptive immune response is mediated by271
receptors that arise through a highly regulated process of recombination of a diverse group272
of gene segments followed by selection. This leads to a clonally diverse repertoire of antigen273
receptors on lymphocytes that can recognize a wide array of pathogens [32,33]. Historically,274
the adaptive immune system was classified into two parts- the humoral immune response and275
the cell mediated immune response. The key players for the humoral immune response were276
B cells and antibodies while for cell-mediated immune response they are T cells [34–37].277
There is now increasing evidence of cells that show properties of innate and adaptive immune278
system. One such example is NK cells which show properties of innate immune system such279
as inducing death of tumor cells and virus infected cells in absence of specific immunization.280
They also show properties of adaptive immune system such as antigen-specific immunologic281
memory [38,39].282
B cells: B cells produce antibodies in response to a breach in the host system. Antibodies283
are immunoglobulin molecules with an antigen-binding site that facilitates its binding to an284
antigen in a highly specific manner [41]. B cells arise from the hematopoietic cells that are285
produced in the fetal liver during pregnancy, and at a later stage in the Bone Marrow (Figure286
1.2) [42, 43]. Within these microenvironments, precursor cells undergo proliferation and287
diversification through a series of differentiation events involving the ordered rearrangement288
of variable (V), diversity (D), and joining (J) gene segments thus giving rise to a wide range289
of B cell receptors (BCRs) that can recognize many different types of molecules [44–46].290
Immature, naive B cells constantly migrate between secondary lymphoid organs through the291
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Figure 1.2: Immature B cells are made in the bone marrow after which they are exposed to antigens
to give rise to either memory B cells or plasmablasts. Figure reproduced from [40].
blood where they search to meet their cognate antigen supplied by the circulating lymph and292
get activated [47]. Antigen loaded B cells then interact with antigen-specific helper T cells293
which give them signals to proliferate [48]. From this pool of B cells, some go on to become294
extrafollicular antibody-secreting plasma cells while some form germinal centres. Germinal295
centres serve as a site for B cell affinity maturation which involves repeated exposure of same296
antigen so that the antibodies produced have a higher affinity for the antigen and somatic297
mutation which involves diversification of B cell receptors to allow to combat new threats [49].298
Throughout their development, B cells are tested for reactivity against autoantigens. These299
take part in two phases known as the central tolerance, which takes place at the immature300
B-cell stage [50] and peripheral tolerance which takes place once the B cell has left the301
primary lymphoid organs [51,52]. B cells that encounter self-antigen are removed from B-cell302
repertoire by negative selection [53, 54]. Negative selection has been proposed to take place303
by three distinct mechanisms: deletion by apoptosis [55, 56], induction of anergy [57, 58], or304
alteration of the antigen receptor specificity by receptor editing [59, 60]. This is the first305
checkpoint that the B cells undergo and the site of a B cell’s first antigen encounter is a306
determining factor in the mechanism of negative selection that is used [61].307
By producing antibodies in response to the relevant antigens, B cells play an indispensable308
part in the immune system (Figure 1.2). Antibodies can (i) access all the body parts by309
diffusion (ii) opsonize small pathogens like viruses, by coating them and forbidding them to310
interact [62] and (iii) induces a strong recruitment of adaptive immune cells to an antigen so311
that those cells can eliminate the antigen [63]. In addition to the production of antibodies,312
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B cells have also been implicated in other functions such as cytokine production [64] and313
suppression of inflammatory responses [65].314
Figure 1.3: T cell development in the thymus: T cell progenitors enter the thymus in the subcap-
sular region. T cells with T-cell receptor that recognises self MHC are positively selected whereas
T cells that react with self-antigens are removed through negative selection. The cells that egress
are naive T cells. Figure reproduced from [66].
T cells: T cells play a range of functions in the immune system and originate from hematopoi-315
etic stem cells in the bone marrow and eventually migrate to the thymus [67,68]. Here, the T316
cell progenitors localize to the outer regions of the thymic cortex and through recombination317
of genomic DNA segments, unique T cell receptors (TCRs) are generated. In the thymus,318
the T cells undergo selection ensuring both functionality and self-tolerance. The thymus is319
divided into two parts- the cortex where T cell progenitors inhabit to undergo positive selec-320
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Figure 1.4: T cell differentiation pathway. Figure reproduced from [40].
tion and the medulla, where the T cells undergo negative selection and functional maturation321
after which they egress the thymus (Figure 1.3) [69]. Positive selection involves interaction322
of CD4+CD8+double positive (DP) T cells with antigen presenting cells (APCs). Successful323
recognition of the ligand gives rise to single positive (SP) T cells which are T cells committed324
to either the CD4+ or CD8+ T cell lineage. Other than lineage commitment, recognition of325
the ligand provides the signal for cell survival whereas a lack of interaction leads to death326
by neglect [70]. DP and SP T cells also undergo negative selection where T cells reactive to327
self-antigens are eliminated from the repertoire [71,72]. After positive and negative selection,328
T cells egress from the thymus. These T cells are in a naive, resting phase and are activated329
to protect the body in case of an infection (Figure 1.4) [73].330
These T cells need activation to give immune response. T cells can only be activated in331
the presence of two independent signals to avoid against premature or excessive activation332
(Figure 1.5) [74,75]. The first signal is antigen specific and is received through the interaction333
of the TCR with an antigen peptide and MHC complex on the surface of APC. The second334
signal is antigen independent and involves the interaction of a co-stimulatory molecules on335
the APC and the T cell surface. One of the most researched co-stimulatory molecules is the336
CD28 receptor expressed on the T cell which recognizes and interacts with CD80 and CD86337
expressed on the APC surface [76–78]. T cell activation is a tightly regulated process and338
in the absence of either of the signals described above, T cells fail to activate and it leads339
to T cell anergy [79–81], deletion or the development of immune tolerance. This regulation340
is part of peripheral tolerance [82, 83]. After infection, the time taken for activation of T341
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cells is nearly ∼ 48hours and this delay allows the innate response to combat the infection342
before the T cell mediated immune response is initiated [84]. The three main properties343
of T cell antigen recognition are sensitivity, specificity, and context discrimination [85]. T344
cell ligands are displayed at a low number which has led to T cells being highly sensitive.345
This allows them to recognize very few molecules of antigens on a synapse which is an346
interface between an APC and a T cell [86]. The recognition must be specific to allow for347
discrimination and identification of the relevant antigenic peptide–MHC complexes among348
the pool of homologous complexes of the same MHC molecules. Lastly, T cells are able to349
interpret the context of antigen presentation so as to initiate an effector response to harmful350
antigens while ignoring harmless or self-antigens.351
Once the infection is removed, ∼ 95% effector T cells undergo a phase of contraction, where352
most cells die by apoptosis while a small pool remains as memory T cells and mount a faster353
response in face of renewed exposure to the relevant antigen [87–89].354
Figure 1.5: T cell activation requires the presence of two signals simultaneously. Figure reproduced
from [90].
In response to activation signals, CD4+ T cells differentiate into T helper cells, Th1 Th2,355
Th9, Th17 and regulatory T cells [91, 92]. These cells differ on the basis of their respective356
cytokine profiles. On the other hand, CD8+ T cells differentiate into cytotoxic T lymphocytes357
(CTLs), Tc2, Tc9, Tc17 or CD8+ T regulatory fate [93–95].358
24 CHAPTER 1. INTRODUCTION
My doctoral research topic pertained to T cells. In particular, I worked on two research projects359
about the activation of T cells and the killing mechanisms employed by CTLs in vivo.360
1.2 T Cell Activation361
Naive T+ cells constantly scan secondary lymphoid organs for the presence of non-self antigen. In362
response to infections, fragments of the pathogen are presented on APCs and naive T cells can get363
activated by interacting with APCs (Figure 1.6). T cell activation requires hours of interaction364
with APCs and the duration of antigen stimulation plays an important role in determining the fate365
of T cells [96]. Recent studies have also shown that T cells have transient interactions with APCs366
before forming stable T cell-APC complexes that eventually lead to T cell activation [97]. Thus,367
during the process of activation, T cells interact with cognate APCs for hours while alternating368
between forming stable synapses and motile kinapses [98, 99]. The activation of T cells through369
synapse formation is well studied and the TCR signaling that arises as a consequence of synapse370
formation has been shown to persist for several hours [100, 101]. Studies have also exhibited that371
an elevated signal strength as a consequence of a high peptide density or a high TCR ligand affinity372
leads to synapses rather than kinapses [102,103].373
T cell activation in the lymph node has been shown to take place in three different phases:374
(i) transient successive contacts during the first activation phase, (ii) stable contacts leading to375
cytokine production during the second phase, (iii) an enhanced motility and rapid proliferation376
during the third phase [104].377
While interaction between APC and T cells is required for the activation of CD4 and CD8 T378
cells, the major difference lies in the MHC molecules employed by each type of T cell. The two379
types of MHCs that play an important role in antigen presentation are MHC class I and class380
II [105]. CD4 T cells bind with MHC class II molecules whereas CD8 T cells bind with MHC class381
I molecules.382
A stable interaction between a T cell and APC involves the formation of an immunological383
synapse (IS) [106, 107] (Figure 1.7). The IS facilitates T cell activation also known as “priming”384
which brings about changes in the migration, cell growth and proliferation, expression of different385
gene programs that can be effector or memory phenotype, and an increase in the killing capacity386
of the cells [108]. The IS consists of an assembly of pMHC-TCR, co-stimulatory/inhibitory and387
adhesion interactions at the contact interface between the T cell and APC [109,110].388
The activation of T cells leads to the clonal expansion of specific effector T cells that will in turn389
leave the lymphoid organs and enter the bloodstream to move towards the sites of infection. One390
such example of an effector cell is the CTL which induces cell apoptosis by different mechanisms,391
including release of cytotoxic granules at the synapse interstitial area (described below).392
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Figure 1.6: Naive CD8 T cells that are circulating through the secondary lymphoid organs can
be activated by APCs such as dendritic cell. Once activated, CTLs can either undergo further
maturation and act as effector T cells or they can exit into the lymph and migrate to the site of
infection and interact with the target cells. Figure reproduced from [111].
Figure 1.7: An immunological synapse and various molecules associated with it: CD8+ T cells
interact with APCs in order to get activated. Figure reproduced from [112].
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1.3 Signal Integration During Activation393
Earlier studies, implicated synapses in the effector function [113] whereas kinapses were thought394
to be important for a better exploration of the area in the lymph node [114]. But recently, T cell395
activation has also been shown to be achieved through kinapses. T cells can engage multiple DCs396
consecutively and sum the signals obtained from the interactions [115, 116]. This implies that T397
cells retain some biochemical memory of previous encounters which accumulates until the T cell is398
activated. Certain in vitro studies have also shown that T cells can gather signal from recurring399
interactions with APCs despite a lapse in time between two consecutive interactions [117,118].400
Additionally, it has been shown that T cells ”counted” the number of TCRs which were triggered401
in the course of interaction with APCs and a response was seen when ∼ 8000 TCRs were triggered.402
In the presence of costimulatory signals, T cells were more sensitive to antigen stimulation and403
a response was seen at ∼ 1500 TCRs [119]. As discussed in Section 1.2, T cells activation takes404
place in three different phases. It has been shown that T cells do not get activated or proceed to405
the phase two when the antigen is below a certain threshold [102]. Together, these results suggest406
that T cells get activated over a series of interaction with APCs and integrate the signals received407
at each interaction.408
1.4 Killing by CTLs409
On coming in contact with a target cell, CTLs initiate membrane-membrane contact between the410
TCR on the T cell and the peptide-MHC complex on the target cell. After a few minutes of411
initiating contact, the CTL cytoskeleton reorganizes such that the microtubule-organizing center412
(MTOC) moves toward the synaptic interface (Figure 1.8) [120,121]. This rearrangment facilitates413
the transport of lysosomes which contain cytolytic proteins from the CTL to the target cell [122].414
This mechanism is indispensable in ensuring the secretion of cytotoxic components such as perforin415
and granzymes [123]. In addition, an increase in perforin pore formation and target cell killing416
is seen as a consequence of mechanical force exerted by the killing synapse on the target cell417
membrane [124,125].418
CTLs kill infected cells by different pathways.419
1. Granzyme mediated pathway: Granzymes are proteases implicated in the induction of420
target cell death by CTLs [127]. On being secreted by CTLs, granzymes cleave extracellular421
and intracellular proteins in the target cell [128]. The main types of granzymes are granzymes422
A, B, H, K and M [129]. Out of all the granzymes in humans, granzyme B is the most well423
researched granzyme and is the main force behind the efficient induction of caspase-dependent424
apoptosis [130,131].425
The original view regarding granzyme mediated cell death involved the function of perforin426
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Figure 1.8: On recognizing MHC class I molecule and initiation of contact between TCR and pep-
tide antigen, the centrosome polarizes towards the synapse and attaches to the plasma membrane.
The granules then move towards the centrosome and they are ejected into the synaptic cleft leading
to apoptosis. Figure reproduced from [126].
polymerization to induce a pore (Figure 1.9a) [132]. Perforin is a protein with multiple427
domains that is stored in the cytoplasmic granules of the CTL along with a family of serine428
proteases known as granzymes [133]. After establishing a contact with a target cell, these429
granules are secreted by the CTLs. Perforin monomers then assemble and insert into the430
plasma membrane of target cells to give rise to plasma membrane pores by polymerization431
[134,135]. These perforin channels then facilitate the entry of other granzymes into the target432
cell which cleave substrates at key aspartic acid residues leading to target cell apoptosis.433
This is at present the accepted view for functioning of perforin in CTL mediated cytotoxicity434
however there have also been studies showing that perforins can deliver granzymes to target435
cells without forming pore in the membrane [136].436
The role of perforin is highly debated but in perforin deficient mice, it has been shown that437
the cytotoxicity of CTLs and NK cells is highly affected [137,138] implying that perforin plays438
an important role in CTL and NK cell mediated cytotoxicity. The exact role of perforin in439
killing of target cells came under scrutiny when a receptor for granzyme B was discovered.440
By means of the receptor, granzymes could be taken up by receptor-mediated endocytosis441
where perforin releases granzymes stored in endosomes into the target cell (Figure 1.9b).442
Additionally, granzymes have been shown to bind to target cell surface and enter the target443
cell through membranes damaged by perforin (Figure 1.9c).444
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Figure 1.9: Pathways for entry of granymes: (a) Perforin pore dependent granzyme entry into
target cell; (b) Uptake of granzymes by perforin mediated cell damage; (c) Receptor mediate
endocytosis where perforin acts to release granzymes from the endosomes. Figure reproduced
from [139].
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2. FAS mediated killing: Fas (CD95) is a membrane protein expressed on many different445
tumor cells and belongs to the tumor necrosis factor (TNF) receptor superfamily. The446
interaction of Fas ligand (FasL) expressed on CTL membrane with Fas protein on the infected447
cell induces apoptosis of the target cell by triggering a cascade of caspases [140–142]. The448
association of Fas and FasL leads to the formation of a death-inducing signaling complex449
(DISC) which is a multi-protein complex which in turn activates caspase-8, belonging to the450
family of cysteine proteases [143,144]. This activated caspase-8 sets in motion the downstream451
apoptotic events [145]. The cascade of caspase activation culminates into the activation of452
caspase-3 [146]. Activated caspase-3 is partially or completely responsible for the proteolysis453
of a number of substrates, eventually leading to cell death [147].454
Other than Fas, studies have also shown that FasL can bind to other proteins such as DcR3455
which belong to a group of proteins known as decoy receptors that can inhibit apoptosis and456
serve as regulators of immunity and inflammation [148, 149]. Due to the ubiquity of Fas on457
tumor and cancer cells, the modulation of FAS pathway has been an area of research that458
could lead to efficient anticancer therapy [150,151].459
The above two mechanisms are the most significant pathways of CTL mediated killing but460
it has also been shown to function through other pathways such as tumor necrosis factor (TNF)461
production [152].462
A non-apoptotic pathway of cell death is necroptosis which is a much more rapid form of cell463
death [153–155]. While apoptotic death is an immunologically silent process, death by necroptosis464
releases molecules that lead to inflammation which is known as necroinflammation [156,157].465
The effector function of CTLs has been studied most in context to the response to HIV infection466
[158]. Studies have also shown that HIV in the blood shows a sharp increase followed by a peak467
and an eventual decline to a set point, where it persists for many years in absence of treatment468
HIV [159]. Recent studies have shown also that CTL mediated killing might not be a very efficient469
process and target cells may need multiple contacts with CTLs before they are killed [111,160].470
1.5 CTL Exhaustion471
T cell exhaustion, also known as T cell dysfunction is seen in various chronic infections and cancer472
[161, 162]. It arises as a result of continued stimulation of the TCR in the presence of a large473
amount of antigen or in case of exposure to antigen for an extended period of time [163].474
T cell exhaustion has been shown to take place in phases such that certain properties are lost475
before others [164–167]. A loss in proliferative capacity, ex vivo killing and the production of IL-2476
is the first step of T cell exhaustion. Next, T cells lose the ability to produce tumor necrosis factor.477
Eventually, the T cell is unable to degranulate or produce beta-chemokines. In extreme cases, the478
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final stage of T cell exhaustion is the removal of virus-specific T cells [161]. In humans, HIV-specific479
CD8+ T cells have been shown to have a partially or no effector function [168]. Characterization of480
T cells at different levels of exhaustion shows that the level of expression of the inhibitory receptors481
such as PD-1, CTLA-4, and Tim-3, correspond to the extremity of exhaustion [169].482
Understanding how T cell exhaustion can be reversed or prevented is a dynamic field as it opens483
up the possibility of identifying ways to combat diseases that are till now incurable [170–172].484
1.6 Assays to Study CTL Mediated Killing Dynamics485
The importance of T cells in viral infections such as HIV, pneumonia and other diseases such as486
cancer [173–176] along with their use in immunotherapies [177–181] makes the study of T cell487
mediated killing an incredibly fascinating field.488
The main mechanisms of CTL killing rely on cell to cell contact, and the presentation of antigen489
by the infected cell. However, the efficiency and dynamics of CTL killing are poorly described.490
Different methods to monitor and extract quantitative information about CTL killings will be491
presented in this part.492
1.6.1 In Vitro Assays493
The first assay that gave an insight into the measurement of CTL mediated killing was 51Cr494
release assay which involved the incubation of CTLs with target cells labeled with radioactive495
chromium [182]. When they are killed, target cells release the radioactive chromium which is496
measured and used as a quantification of the number of killed target cells and the duration in497
which these killings took place. But a study involving mathematical modeling of data obtained498
from the 51Cr release toxicity assay showed that the release of chromium was not instantaneous and499
cannot be used as an accurate measure of killed target cells [183,184]. Additionally, a consequence500
of the experiment being carried out in a liquid suspension leads to a readout that does not reflect501
the 3D dynamics of CTL looking for target cells among other complexities that arise in vivo [185].502
The chromium assay showed that target cell lysis proceeds linearly over the observed period of503
time but due to the cost and hazard of handling radioactive material, it is an expensive procedure.504
Alternative assays have been developed that do not make use of radioactive material such as a505
killing assay that makes use of a fluorescent dye called calcein [186]. Calcein enters the target cell506
cytosol through the plasma membrane and once the target cells are killed, calcein is released into507
the supernatant leading to a loss in fluorescence. It was shown that the intensity of fluorescence508
corresponds to the number of target cells with calcein in a linear manner. This information opens509
up the possibility of calculating the fraction of killed target cells at a particular time. An alternative510
assay involved loading target cells with calcein and observing the live fluorescent target cells with511
a cell-imaging multimode reader [187].512
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Despite providing insights into the fraction of killed target cells, the above assays did not513
answer questions about killing at an individual cell level. To this end, a single cell method was514
developed where complexes of CTL and target cells that were bound to each other were isolated515
and studied through microscopy [188, 189]. While this method gave a peek into the killing at516
an individual cell level, it lacked information about the complex 3D dynamics that take place in517
biological systems. To study the 3D dynamics, a collagen-gel assay was used. It consisted of a518
3D fibrillar collagen matrix containing CTLs. The interface of the collagen gel and culture dish519
contained target cells and with this assay, we could monitor data that represented efficiency of520
CTL migration, conjugation and killing of target cells [190]. The number of surviving target cells521
in this assay are studied by flow cytometry and the gel can be observed by time-lapse microscopy522
to study killing dynamics.523
1.6.2 In Vivo Assays524
To study the dynamics of CTL mediated killing in a system that has all the complexities of a525
real system, in vivo assays were developed. Here, two different in vivo assays used to study the526
dynamics of CTL mediated killing are described.527
Figure 1.10: In vivo assays involves the injection of peptide-pulsed and unpulsed target cells into
model organism. Some target cells are lost while others migrate to the spleen where they are killed
by CTLs. Figure reproduced from [184].
1. Adoptive transfer of infected cells. Through the process of adoptive transfer, infected cells528
are transferred into the model organism (Figure 1.10). A widely used approach involves the529
transfer of equal peptide-pulsed target cells and unpulsed cells into the organism. Peptide-530
pulsed target cells are killed by CTLs whereas unpulsed target cells remain unaffected. By531
observing the ratio of surviving pulsed and unpulsed target cells at various time intervals,532
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the killing rates can be elucidated [191,192].533
2. Another approach involves labelling infected/target cells with a fluorescent protein, follow-534
ing which the dynamics can be observed using two-photon microscopy [111]. Two-photon535
miscroscopy is used to obtain three-dimensional imaging in vivo and employs two lasers to536
excite a fluorescent tag of a protein and recording the emitted light to study the behavior537
of the protein [193, 194]. The second method is an indirect way to observe CTL killing rate538
and is mostly used for viruses such as HIV and SIV. Some infected cells have been shown539
to have mutated CTL epitopes which cannot be recognized by CTLs and can thus, escape540
apoptosis [195]. The rate of increase in the frequency of the mutated epitope bearing cell541
is used to quantify the killing rate of CTLs and a higher increase in frequency of the cell542
implies a higher CTL mediated killing rate [196].543
1.7 Mathematical Models of Cytotoxic T Lymphocytes544
An important step in gaining new insights into a system is creating and studying mathematical545
models. A model can be used to interpret the observed experimental data, propose and test new546
hypotheses, and suggest new experimental approaches to further our knowledge of the system.547
The model recreates the behavior of the system being studied based on the known and observed548
properties. The benefit of such a model is that it can be used to explore aspects of a system549
that cannot be explored using only experimental approaches. Additionally, the ease and speed of550
testing hypotheses, makes an established model a powerful tool.551
CTL mediated killing modeling and assays used to observe CTL mediated killing have always552
been entangled due to the complexity of linking observed killing to cellular decisions. The observed553
dynamic interplay between CTLs and infected cells raises many questions about the mechanisms554
and quantification of killing that can be answered by modeling of their behavior.555
Modeling of CTL mediated killing follows three major paths: (i) equating CTL mediated556
killing to an enzyme substrate system, (ii) a differential equation approach and, (iii) creating in557
silico models that recreate the experimental environment and running simulations.558
One of the simplest enzyme substrate model of CD8+ T cell mediated target cell killing has559
been shown to follow the law of mass action where the death rate of individual target cells is560
proportional to the total number of specific CD8 T cells in the spleen. This has been observed561
even in cases where the effector to target ratios vary [197]. On the other hand certain studies have562
shown saturation of death rate with CTL densities [198] or target cell densities [199]. Mathematical563
models also allow for comparisons between effector and memory CTL function which show that564
effector CTLs have approximately a double killing rate compared to memory CTLs [200]. In565
contrast, a model which takes into account the gradual migration of target cells into the spleen566
showed that effector CTLs do not kill significantly better than memory CTL [201].567
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In a series of studies consisting of a simulated environment made to resemble a portion of the568
lymph node by making use of a 2D cellular Potts model, Gadhamsetty et al explored killing regimes.569
These included monogamous, where one CTL can kill just one infected cell at a time; simultaneous570
killing, where one CTL can kill multiple infected cells at the same time; joint killing, where multiple571
CTLs kill a single infected cell; and mixed killing, where multiple CTLs can kill infected cells572
simultaneously. From this study, it can be seen that the killing rate saturates comparably when573
increasing the CTL or target cell density [202,203].574
To understand the dynamics of how CTLs interact and kill infected cells in a three-dimensional575
(3D) tissue in vivo Graw et al [198] developed a 3D model to look at CTL mediated killing through576
the lens of CTL motility where they showed that the killing is linear with respect to the frequency577
of target cells but saturates with respect to the frequency of CTL. Interestingly, Gadhamsetty578
et al also showed that the dimensionality of Potts models affects the efficiency of CTL mediated579
killing of target cells [204]. These models use an empirical probabilistic mechanism but the killing580
mechanisms at an individual cellular level remained unresolved.581
1.8 Quantification of Killing Dynamics582
A conceptual understanding of the mechanisms is imperative to understand the working of CTL583
mediated cytotoxicity. But a crucial step in enhancing our knowledge of the field is not possible584
without a clear understanding of the numbers associated with the process. Thus, an important585
aspect of understanding the behavior of a system that includes killing of infected cells is quantitative586
analysis.587
Quantification of CTL mediated killing dynamics is studied by two major ways:588
1. Per capita killing rate (PCKR): This method gives the number of killed infected cells589
per CTL in 24 hours [111].590
2. Half life of target cell: By using the chemical kinetics approach, this is the time taken for591
half the target cells to be killed and is computed as ln 2/rk where rk is the rate of target cell592
killing [184].593
Recently, Halle et al showed that infected cells need to be contacted by CTLs multiple times to594
initiate apoptosis [111]. While these quantitative methods provide a way to estimate the efficiency595
of CTLs, there is no established method to quantify the effect of increasing number of CTL contacts596
on infected cell death.597
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1.9 Scope of Doctoral Research598
In 2016, Halle et al reported CTL-mediated killing kinetics analysed by 2-photon microscopy in599
vivo. They tracked CTLs interacting with virus-infected cells in vivo [111] inside lymph nodes600
with fluorescent reporter viruses that allow the direct observation of the infected target cell over601
time. These studies relied on morphological disruption of the target cell as evidence for irreversible602
target cell death. This study showed that infected cells need multiple contacts with CTLs to get603
killed.604
In my doctoral research, I tackled the following questions:605
1. Is there a way to quantify the effect of increasing number of contacts with CTLs on infected606
cell death probability? What are the properties of this quantification method and can it be607
used to study the dynamics of other systems? (Chapter 2)608
2. Could the need for multiple contacts with CTLs for an infected cell to get killed indicate a609
mechanism whereby CTLs or infected cells change their properties? Can a modulation in610
system properties give an agreement with observed datasets? (Chapter 4)611
3. Do experimental biologists need to care about the duration of experiments? Does this factor612
affect the observed results? (Chapter 5)613
4. What is the impact of a higher antigen concentration on T cell activation? Do the motion614
properties of T cells change as a consequence of signal integration during T cell activation?615
(Chapter 6)616
In the upcoming chapters, I have elaborated further on these problems and I have proposed617
solutions to all of the questions posed above.618
Chapter 2619
Experimental Setup and Data620
Analysis621
2.1 Experimental Setup622
In 2016, Halle et al studied in vivo CTL mediated killing of infected cells inside a lymph node623
by employing a modified MCMV reporter virus [111]. The experimental setup consisted of in-624
fecting mice with a modified murine cytomegalovirus (MCMV-∆3D) which did not affect MHC625
presentation. The MCMV expressed a fluorescent protein (mCherry) that facilitates observing the626
system through two-photon microscopy. In addition, the MCMV expressed a specific ovalbumin627
(OVA) protein. Before infection, T cells specific for OVA, carry another fluorescent protein are628
adoptively transferred to the mice. The CTLs expressed a green fluorescent protein whereas the629
infected cells expressed a red fluorescent protein. The CTLs specifically recognized infected cells630
and killed them. The micro-anatomical regions containing virus infected cells inside lymph nodes631
were observed. In these experiments, just a small top portion of the tissue is observed where CTLs632
are recruited to kill infected cells. By making use of two-photon microscopy, the killing of infected633
cells mediated by CTL is recorded and studied. The observations include movement of T cells,634
the number of contacts between the infected cells and CTLs, the duration of these contacts, the635
number of contacts after which an infected cell dies and disappears.636
In vivo imaging of CTL mediated killing activity revealed that infected cells need multiple637
contacts with CTLs in order to get killed. It is not known whether CTLs become more lethal with638
increasing contacts with infected cells or if infected cells become more susceptible to cell death639
with increasing number of contacts with CTLs. The need for multiple contacts with CTLs for640
infected cell death raised a question about how increasing number of contacts with CTLs affect641
cell death. To this end, a mathematical analysis was used in Halle et al. [111] to calculate the642
ratio of killed target cells at each contact to total cells at each contact. Here, I analyzed the used643
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mathematical analysis and show its dependence on time of measurement. In its place, I proposed a644
new probability of transition analysis (PTA) that gives the observed probability of killing infected645
cells at each contact.646
2.2 Infected Cell Fates647
In the experimental system described in [111], a single alive infected cell with 0 or more contacts648
with CTLs can either get a next contact with a CTL or it may not. At the end of this particular649
contact, the infected cell can then either die or stay alive. In order to understand a general system650
with these characteristics, I studied the behaviour of ki, pi, Ai and Di (Table 2.1).651
Symbol Meaning
ki Fraction of infected cells with exactly (i− 1) contacts that get the ith contact
pi Probability of cell death after getting the i
th contact with a CTL
Ai Number of infected cells that are alive at exactly i contacts
Di Number of infected cells that are dead at exactly i contacts
Table 2.1: Format of data output of infected cells killed by CTLs
A decision tree of the system under study can be represented as shown in (Figure 2.1). The652
infected cells shows a cyclical behavior involving contact with CTL followed by cell death decision653
and for each infected cell, this cycle is observed until the infected cell dies or the experiment is654
over (Figure 2.2a). Thus, the number of contacts with CTLs that an infected cell gets is a function655
of time. An experiment with a longer duration would imply that more infected cells get higher656
number of contacts with CTLs. At time t0, all infected cells have had no contacts and infected657
cells in the system continue getting contacts with CTLs until they die and are removed from the658
system. From the flowchart, we can also infer that each infected cell behaves independently and659
the number of contacts that it gets does not depend on the behavior of other infected cells. Thus,660
at the end of the observation window, the pool of infected cells remaining in the system have had661
different number of contacts with CTLs and the infected cells that died also did so after getting662
different number of contacts (Figure 2.2b).663
2.3 Analysing in vivo CTL Killing Activity664
To study the CTL killing activity, the number of CTL contacts received by a target cell to get665
killed were monitored. The data is organized in a table as shown in Table 2.2. The number of666
interactions are with respect to the infected cells and represent the times a CTL came in contact667
with a particular infected cell during the time-window of observation. The cells are tabulated668
based on whether they died during the observation window or if they remained alive at the end of669
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Initial infected cell population 
Infected cell population
with exactly 0 contacts with 1 contact 
Infected cell population
population with 1 contact 
Killed infected cell
population with 1 contact 
Alive infected cell
Infected cell population
with exactly 1 contact with 2 contact 
Infected cell population
population with 2 contact 
Killed infected cell
population with 2 contact 
Alive infected cell
Infected cell population
with exactly 2 contacts with 2 contact 
Infected cell population
population with 3 contact 
Killed infected cell
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Figure 2.1: Decision tree for infected cell behavior.
the observation.670






Table 2.2: Format of data output of infected cells killed by CTLs
To study the effect of increasing number of interactions with CTLs on target cell death, the671
ratio of killed target cells at each contact to total cells at each contact was calculated in [111]. For672
each value of i, the number of dead infected cells is normalized against the total number of infected673





In the study [111], it was shown that the value of Rdead, i increased with increasing values675
of i. But the significance of this ratio remains unexplored. In order to understand the physical676
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Figure 2.2: (a) Flowchart for infected cell fate, (b) The number of dead and alive infected cells
have a variable number of CTL contacts throughout the observation time.
Figure 2.3: Basic properties of the experimental system: The fraction of cells with (i− 1) contacts
that get the ith contact is ki and the probability of infected cell death at the i
th contact is pi.
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significance of this ratio, I derived a general expression for the values of Ai and Di in a system of677
N infected cells (Figure 2.4a). Each target cell can get contacts with CTLs and each interaction678
has an associated probability of killing the target cell. The fraction of infected cells with exactly679
(i− 1) contacts that get the ith contact is given by ki (Figure 2.3). The value of ki is a function of680
time, the density of infected cells, the density of CTLs and velocity of CTLs. At each interaction,681
an infected cell can either die or survive. In this system, the fraction of cells that die after getting682
the ith contact is given by pi. The behavior of pi is unknown and could be constant or could683
be a function of time and/or previous contacts. The values of pi for all values of i collectively684
also describe how the fraction of killed infected cells changes at increasing number of contacts685
with CTLs. The surviving cells at each interaction can either get more interactions with CTLs or686
remain alive at the same number of interactions. Using these constraints, I calculated the values687
for Di (infected cells that are dead at exactly i contacts) and Ai (infected cells that are alive at688
exactly i contacts). It is important to note that any infected cell that has had ≥ i interactions has689
at least had i interactions with CTLs. Thus, I also calculated another set of cells given by Cmin,i690





where m is the maximum number of contacts that any infected cell has had.692
Using these constraints, we calculated the values for Di, Ai and Cmin, i (Figure 2.4). Out of N693
infected cells, Nk1 cells get the first contact with a CTL as calculated from the definitions discussed694
above (Figure 2.4b). Nk1 are all infected cells that have at least 1 contact with a CTL and is the695
expression for Cmin, 1. Out of these Nk1 cells, Nk1p1 are killed and Nk1(1 − p1) survive (Figure696
2.4c). Continuing this cycle further gives us the values of Cmin, 2, A2 and D2 (Figure 2.4d-f). From697
this, we can see how a general population of N infected cells is partitioned into Ai, Di and Cmin, i698
(Figure 2.5).699
The values derived in (Fig. 2.4) are tabulated in Table 2.3. By making use of these general700
expressions, we aim to derive a method of analysis that gives the probability of infected cell death701
with increasing number of contacts with CTLs.702













Figure 2.4: A visual representation of the distribution of infected cell states at the end of the
experiment. For a population of N infected cells, I computed the value of Ai, Di and Cmin, i (Table
2.1): (a) The system consists of N cells, (b) Out of the N cells, a fraction of k1 gets the first
contact, (c) Of all cells that get the first contact, a fraction of p1 cells die, (d) Out of the infected
cells alive at the first contact, a fraction of k1 get the first contact, (e) A fraction p2 cells are killed
out of all infected cells that get the second contact, (f) A general distribution of a system with the
no infected cell with more than 3 contacts.
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Contacts Ai Di Cmin, i
Di
Cmin, i
0 N(1 − k1) 0 N 0
1 Nk1(1 − p1)(1 − k2) Nk1p1 Nk1 p1
2 Nk1k2(1 − p1)(1 − p2)(1 − k3) Nk1k2(1 − p1)p2 Nk1k2(1 − p1) p2
: : : : :
m N(1 − km+1)
∏m








j=1 (1 − pj)] pm
703
704
2.4 Ratio of Killed Target Cells at Each Contact to Total705
Cells at Each Contact706
The values of Ai, Di and Cmin, i are dependent on pi and ki. As discussed above, the value of707
ki is further dependent on a host of other system properties. This makes it difficult to conclude708
anything about the system dynamics by just observing these values.709
The observations about the impact of time on the number of contacts that a target cell gets710
with CTLs raise the question if the quantitative analysis described in [111] is independent of time711
and if it accurately represents the change in infected cell death properties with increasing number712
of contacts with CTLs. In order to check this, I computed a general expression for Rdead,i as713
described in equation (2.1) for the system, using the values obtained in Table 2.3.714
Rdead,i =
pi
1 + ki+1(pi − 1)
(2.3)
While the value computed for Rdead,i is dependent on the value of pi, it is also dependent on715
the value ki+1. As discussed in Section 2.3, the value of ki is a function of time, density of infected716
cells and CTLs and velocity of CTLs. Thus, the value of ki is dependent on time as the fraction717
of cells that get more number of contacts will increase with time.718
The simplified expression also shows that the ratio of killed target cells at each contact to total719
cells at each contact calculated in this way does not accurately represent the effect of increasing720
contacts on infected cell death. The fraction of dead infected cells at the ith contact is given by pi721
at different interactions. As seen in equation (2.3), the value of Rdead,i at each contact is a function722
of pi and ki+1. An observed change in the value of Rdead,i could be an effect of change in pi or ki+1723
whereas the effect of increasing contacts on infected cell death is only represented by pi. Thus,724
this value does not provide a quantification of only the intrinsic killing properties. This suggests725
that a new method to analyse the data is needed where the calculated values at an interaction i726
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Table 2.4: Proposing a new analysis method (pobs, i) to study the killing probability of CTLs.




Figure 2.5: A general distribution of a system with the m being the maximum number of contacts
that any infected cell has.
2.5 Requirements from New Analysis728
For the system described above with N cells, the values that can be observed are Ai and Di for729
different values of i. The value of Cmin, i can be computed from values of Ai and Di (equation (2.2))730
but the values of ki and pi cannot be observed. As discussed, the probability of an infected cell731
getting killed at each contact is given by pi. To understand the dynamics of the system, I would732
need to compute a way to calculate the observed probability of killing at each contact (pobs, i) that733
is only dependent on the value of pi. By doing this, I can be sure that any change in the value of734
pobs, i is a consequence of the change in killing properties of the system. The dependence of Rdead, i735
on ki+1 rules it out as a potential analysis method.736
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2.6 Probability of Transition Analysis737
The analysis of the ratio of killed target cells at each contact to total cells at each contact is738
dependent on time and does not give a value for the rate of killing with number of interactions739
as shown above. Hence, I proposed a new probability of transition analysis (PTA) to analyse the740
experimental data that would accurately represent the killing properties of the system by making741
use of the general expressions shown in Table 2.3. The analysis calculates the probability at each742
contact for an infected cell to transition from alive to dead.743
The analysis I proposed to understand the system is calculating the probability of infected cell744
death with increasing CTL contacts. The probability of dead cells at exactly the ith interaction is745
given by normalizing the number of dead infected cells with exactly i interactions by the number746
of infected cells that have survived the ith interaction. The number of infected cells that have747
survived the ith interaction consist of all infected cells that have had i or more interaction (Cmin, i).748
From Table 2.3, it can also be seen that the ratio of Di to Cmin, i for each contact is pi (Table 2.4).749
Thus, I propose that a more reliable measure to represent the killing dynamics is by calculating750











In the previous section, I have proposed PTA as an alternative to the analysis done in equation754
(2.1) [111]. It is extremely crucial to note that the value of pobs,i equals pi. Thus, if the value of755
pi is a function of other properties of the system, the PTA will reflect that.756
As an example, in a given system the value of pi for a given value of i increases with time757
and the system evolves such that CTLs become more lethal with time. For such a system, the758
property of CTLs changes accordingly. To carry out the PTA, if the values of Ai and Di for the759
same duration of observation window are measured but at different time points, the pobs,i obtained760
will vary accordingly. Only for a system where the values of pi for all values of i are constant, the761
PTA will give same values at all time points.762
In concise terms, if the value of dpi/dt is non-zero, the values of pobs, i calculated by applying763
PTA will vary at different time points.764
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2.8 CTL Data Analysis765
Having established that the proposed method of analysis reflects the value of pi, I applied the766
method to experimental data obtained by Halle et. al in [111]. The data given in Table 2.5 is used767
to make the plots.768
No. of Contacts (i) Di Ai Cmin, i pobs,i
0 0 96 191 0
1 9 26 95 0.095
2 4 12 60 0.067
3 10 1 44 0.227
4 8 0 33 0.242
5 9 1 25 0.36
6 8 0 15 0.533
7 4 0 7 0.571
>7 3 0 3 1
Table 2.5: Format of data output of infected cells killed by CTLs
As observed from Figure 2.6, using the method of analysis in equation 2.1 gave rise to an increase769
in the ratio of killed target cells at each contact to total cells at each contact. The increase in this770
ratio did not follow an identifiable pattern. But since the analysis was not solely dependent on771
the pi values, I cannot comment further on the reason behind the increase. On the other hand,772
using the method of analysis described in equation (2.5), I can conclude that the value of observed773
probability of killing infected cells increases linearly.774
The observed linear increase in probability of killing infected cells makes it easier to propose775
mechanisms that might be employed in the system to kill infected cells. A potential mechanism776
that gives rise to this linear increase could be a increase in infected cell susceptibility directly777
proportional to the prior number of contacts with CTLs.778
2.9 Applications of PTA779
With the plot in Figure 2.6, I have shown that the PTA gives results that represent the killing780
dynamics of the system. The efficiency of the analysis made me question if it can be used to study781
the transition in other systems. To this end, I investigated the versatility of the PTA and if it can782
be used to understand the dynamics of other systems.783
The general description of the experimental system in [111] can be justified as a species (S)784
undergoing irreversible transition or change to give rise to C as a consequence of a recurring event785
(E) that the species experiences (Figure 2.7). In this case, the species undergoing the irreversible786
transition are the infected cells, the irreversible transition is cell death and the recurring event is787
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Figure 2.6: Comparing the ratio of killed target cells at each contact to total cells at each contact




Here, I propose that for any system that fulfills the criteria defined in Figure 2.7, the PTA can789
be used to study the dynamics of the system. This could include systems where cells are killed790
as a consequence of contacts with killer cells such as the one described above. An example of791
another system whose dynamics could be studied using the PTA is the activation of T cells as a792
consequence of contacts with antigen presenting cells (APCs).793





where Ci is the number of elements that transitioned at exactly i recurring events and Si is the795
number of number of elements that did not transition at exactly i recurring events.796
TimeFigure 2.7: A general framework of a system on which PTA can be applied consists of a species
(S) undergoing an irreversible transition to C due to a recurring event E.
2.10 Summary797
In this chapter, I studied the properties of the experimental system described in [111]. This led798
me to the conclusion that the number of contacts that an infected cell has with CTLs is a function799
of time. Next, I studied the existing analysis, Rdead, i in [111] to understand what insight this800
analysis gives into the CTL mediated killing dynamics. I found that this analysis is dependent on801
other properties of the system and killing properties of CTLs. Thus, a change in value of cannot be802
attributed to just the killing properties. To counter this analysis, I proposed the PTA to analyse803
the experimental data. It is also interesting to note that the PTA is a versatile tool and can be804
used to analyse other systems.805
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Chapter 3806
Agent Based Model of CTL807
Mediated Killing In Vivo808
The observations and the analysis using PTA show that the observed probability of killing infected809
cells at the nth contact increases with n. Additionally, with the experimental setup, we can observe810
the cell movement and interactions. Using the observations obtained from the experiments [111], I811
developed an agent based model (ABM) of 3D CTL killing that mirrors in vivo imaging experiments812
and fairly reproduces the same experimental setting. In this model, I have proposed multiple813
hypotheses for the mechanisms behind CTL mediated killing of infected cells and using the observed814
datasets, I have ranked the best hypotheses to get an insight into the system properties.815
3.1 Agent Based Modeling816
Agent-based modeling is a powerful tool that has been used in recent years to study diverse systems.817
It involves introducing a set of autonomous agents which can behave and interact with other agents818
based on a set of rules used to define them [205]. A major benefit of ABM as a technique is that by819
making use of individual properties of agents, it captures the emergent phenomena and it can be820
used to study the impact of changing one particular property on the emergent phenomena. Since821
different types of agents have different rules, it allows for heterogeneity in the system. Agent-based822
modeling is akin to a computational microscope and can be used to zoom into the system to look823
at properties in exhaustive detail. I chose to carry out my research using an ABM as it gives a824
peek into the mechanisms of killing that are previously unexplored.825
In the system outlined above, the experimental setup by Halle et al. already made us privy to826
the emergent phenomena. Thus, by changing the rules of agents for different hypotheses of killing,827
I could make predictions about system behavior on a cellular level.828
49
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3.2 Three Dimensional Setting and Movement of Cells829
The tissue of the lymph node under observation in experiments is visualized in the ABM as a three830
dimensional cube of dimensions 700*700*700 µm (Figure 3.1a). The agents of this ABM which831
are CTLs and infected cells, are positioned in this continuous three-dimensional space. The size of832
the cube is taken from the experimental settings. It is assumed that the distance along the x and833
y axes is periodic, such that as one cell exits from one side, it re-enters at the other end with the834
other properties remaining the same and maintaining the same velocity vector. In the experimental835
setup, cells can leave from the lower boundary but not from the upper boundary along the z-axis.836
The exit and entry of CTLs in the experimental system leads to a situation where CTLs with837
known history are replaced by CTLs with unknown history. We have assumed the system to be838
impermeable along the z-axis such that cells cannot leave from the upper or lower boundaries.839
CTLs are randomly located throughout the space, whereas the infected cells are placed only in the840
upper 40% (Zlim) of the space with respect to the z-axis, similar to the observed layer of infected841
cells in vivo. The cells are represented as spheres. We assume a nucleus hard-core repulsion where842
CCF known as the collision confinement factor defines the radial size taken by the nucleus. In843
view of this, the cells are positioned in the three-dimensional space to ensure that no two cells do844
physically overlap. The CTLs have a radius of 4.8 µm (RT), and the infected cells have a radius845
of 5.1 µm (RI) (mean calculated from experimental observations).846
The CTLs in the ABM are motile while infected cells are stationary as seen in the experimental847
system. I modelled CTL migration to mimic T cell behaviour as observed by 2-photon microscopy.848
The motion of CTLs is described using a current direction of movement and a speed. The initial849
speed is taken from the distribution obtained from experimental observations (Figure 3.1d) and the850
initial directions are assigned at random. The CTLs have a constant persistence time of 2 minutes851
which is the time that a particular cell moves in one direction before changing directions [206].852
When the persistence time of a CTL is reached, it is assigned a new direction of movement and a853
new speed taken from the distributions obtained from experimental data. Initially, the time that854
each cell has been moving in the same direction is assigned as a random value between 0 and the855
persistence time. This measure avoids synchronization between the movement of CTLs as they are856
all updated to have a new velocity at different time relative to each other.857
3.3 Collision Detection and Interaction Between Cells858
Once the cells have been placed in the three-dimensional space, the respective functions associated859
with each cell type are carried out every time step (0.1 minutes):860
(a) Collision: CTLs that are not interacting with an infected cell at the given time are checked861
for motion. If the CTL has moved in the same direction for a duration equal to or longer than862
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Figure 3.1: Design of the agent-based model for spatial CTL killing activity. (a) 3 dimensional
view of the agent-based model where the infected cells are red and CTLs are green, (b) CTLs in
the model move in a straight direction until a persistence time is reached, then a new direction is
randomly set (α) according to an experimentally measured turning angle distribution, (c) CTLs
interact with infected cells when they are in close proximity to each other (RT- CTL radius, RI-
infected cell radius, ICF- interaction confinement factor, refer to Section 3.3), (d) Speed distribution
of CTLs obtained from experiments [111] and used in the model, (e) Turning angle distribution of
CTL movement obtained from experiments [111] and used in the model, (f) Distribution of contact
duration between infected cells and CTLs (Black- experimental data, blue- log normal plot fitted
to experimental data [111] and used in the model).
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the persistent time, the CTL is assigned a new speed and direction taken from the experimentally863
observed distribution (Figure 3.1d and e). The order of CTLs in which the movement is allowed864
is random to avoid any bias in results.865
Before moving in the assigned direction, the CTLs are checked for collisions. Two cells in the866
system are said to collide if they are at a distance corresponding to the nucleus hard-core repulsion867
or less. More precisely, a CTL collides with a cell when the distance between the centre of the868
CTL under motion and the other cell (infected cell or CTL) is CCF(CTL radius + Cell radius).869
We have set the value of CCF as 0.5 to account for the behavior of a cytoplasm whereby it can870
change shapes to squeeze through smaller openings. Thus, the CTLs are moved in their direction871
of movement as much as possible within the maximum distance that can be covered in a single872
time step until they reach another cell. I have chosen the value of the time step such that it is873
small enough to ensure that a CTL can never pass through another cell in just one time step. Once874
CTLs reach at the threshold distance for collision, the CTL stops moving during that time step.875
(b) Interaction initiation: At each time step, CTLs are checked for interaction. Each CTL876
can interact with only one infected cell at a time, but an infected cell can have interactions with877
multiple CTLs simultaneously. For an interaction to be initiated, the distance between a free878
infected cell and a CTL has to be less than ICF(CTL radius + infected cell radius), where ICF is879
the interaction confinement factor. For the entire interaction period, the CTL is stationary. The880
value for ICF is set to 1.5 to account for the phenomenon that cells can expand pseudopodia to881
interact with another cell. As a consequence of the values taken for ICF, the interaction can be882
initiated before the cells collide with each other.883
(c) Interaction termination: For every interaction, the duration is determined based on a884
predefined distribution. The experimental data for duration of interaction has very few points and885
to achieve a better sampling, the distribution of interaction duration is chosen from a fitted log886
normal distribution, leading to a mean of 2.1 and a standard deviation of 1.2 (Figure 3.1f).887
Once the duration of the ongoing interaction between a CTL and an infected cell equals or888
exceeds the initially assigned interaction time, the interaction is terminated and the CTL is reas-889
signed a new speed and angle. After an interaction ends, CTLs are not allowed to interact during890
the first persistent time. This is done to ensure that the CTL has enough time to move away from891
the cell with which it was interacting previously and to avoid recurring contacts between the same892
two cells due to their proximity to each other.893
3.4 Hypotheses for Cell Death894
Infected cells that are interacting at a given time step are checked for death based on the following895
hypotheses (Figure 3.2):896
1. Null hypothesis: The killing of infected cells is considered to be contact history independent.897
3.4. HYPOTHESES FOR CELL DEATH 53Motility
Null Hypothesis
Interaction
































































































a b c3D setting
d e f





































































Number of contacts per CTL Number of contacts per CTL
















c dInfected Cell Contact Integration Hypothesis
CTL Contact Integration Hypothesis
Damage Related Hypothesis
Figure 3.2: Killing hypotheses: (a) Null hypothesis: Infected cells and CTLs do not retain memory
of prior contacts. Each contact is associated with a constant probability of death. The associated
plot shows the behaviour of CTL killing properties with increasing number of interactions with
infected cells; (b) CTL contact integration: The CTLs retain memory of contacts and at each
contact. The associated plot shows the behaviour of CTL killing properties with increasing number
of interactions with infected cells; (c) Infected cell contact integration: The infected cells retain
memory of CTL contacts. The associated plot shows the behaviour of infected cell susceptibility
to death with increasing number of interactions with CTLs; (d) Damage hypotheses: The CTLs
induce damage to the infected cells. The associated plot shows the change in damage of infected
cell for varying interaction times with CTLs for different hypotheses- constant damage (pink),
damage and repair (green) and saturated damage (purple). The red area represents the damage
greater than the threshold damage after which an infected cell dies.
54 CHAPTER 3. AGENT BASED MODEL OF CTL MEDIATED KILLING IN VIVO
The probability of CTL mediated infected cell killing (p0) remains constant as the number898
of CTL contacts increases, and there is no modulation of cell characteristics as the number899
of contacts increases. Thus, neither the infected cells nor the CTLs retain memory of prior900
interactions. The CTL kills the infected cell at the end of an interaction.901
2. Infected cell contact integration: The probability of CTL mediated infected cell killing in-902
creases linearly with the number of CTL contacts. For each contact, the probability of903
infected cell killing is given by kICI, where kI is constant and CI is the number of contacts904
the infected cell has had, including the current one. In this hypothesis, infected cells become905
more susceptible to cell death with more contacts with CTLs. The increase in susceptibility906
could arise due to potential mechanisms involving storing the number of previous contacts907
by infected cells or signals left by the CTLs around the infected cells. Similar to the Null908
hypothesis, the CTL kills the infected cell at the end of an interaction.909
3. CTL contact integration: Instead of infected cells, the T cells retain the memory of the910
contacts. T cell killing capacity is modulated such that they become more lethal as the911
number of contacts increases. For each contact, the probability of cell death is given by912
kTCT, where kT is constant and CT is the number of contacts the CTL has had. A value of913
a kT > 1 implies that CTL becomes more lethal with increasing number contacts (positive914
maturation), while kT < 1 implies a long-term depletion of T cell killing capacity with915
increasing contacts (negative maturation). Similar to the previous hypotheses, the CTL kills916
the infected cell at the end of an interaction.917
4. Constant damage: A potential mechanism through which infected cells retain memory of918
contacts with CTLs and become more susceptible to cell death, I proposed that CTLs dam-919
age the infected cells. The damage imparted by CTLs to infected cells is assumed to be920
proportional to the duration of contact between the CTL and infected cell and is calculated921




Here Id is the damage of an infected cell, d is the damage rate, and nCTL(t) is the number of923
CTLs that are interacting with the infected cell at time t. From the above equation, it can924
be seen that for an infected cell to reach a damage of 1, a total contact period of 1/d minutes925
is required with CTLs. For an infected cell this is the shortest time from the first contact926
with a CTL after which apoptosis can be initiated. Once an infected cell reaches a threshold927
damage of 1, the death process is initiated. The interaction ends when the infected cell dies,928
or when the interaction time is complete, whichever comes first.929
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5. Saturated damage: Damage of infected cells during a single interaction with CTLs is limited930
to a certain duration Tmax . Once an interaction exceeds Tmax, the CTLs no longer damage931
the infected cells. This measure accounts for the short-term fatigue of CTL in contact. For932







d, if Tc,i < Tmax
0, if Tc,i ≥ Tmax
where Id is the damage of the infected cell, d is the damage rate, Tc,i is the time duration934
of the ith interaction and nCTL is the total number of CTL contacts that the infected cell is935
currently having.936
6. Damage and repair: As a compensatory mechanism for infected cells, I have assumed that937
while infected cells can get damaged by CTLs, they can also repair themselves. Similar to938
the damage hypothesis, the damage is proportional to the duration of contact and the repair939
is proportional to the damage of the infected cell. At each time step, the damage for an940
infected cell is updated according to:941
dId
dt
= nCTLd− rId (3.2)
where Id is the current damage of the infected cell, d is the damage rate, nCTL is the number942
of CTLs currently interacting with the infected cell and r is the repair rate.943
To get an idea about the damage of an infected cell, I solved the above differential equation944




(1 − e−rt) (3.3)
Using the equation (3.3), the duration of the first contact needed to reach a damage of 1946










Once the decision for an infected cell to die is taken, the infected cells do not immediately disappear948
from the system. Instead, they persist for a period of time taken for cell to die called Tdeath. During949
this period, the infected cells are in state of activated apoptosis. The value of Tdeath is treated as950
an unknown parameter and is considered a constant value. A non-zero value of Tdeath raises the951
question of contacts between an infected cell in activated apoptosis and CTLs (zombie contacts).952
In the simulations, zombie contacts may or may not be allowed (in this case, CTLs ignore the953
dying cells). If zombie contacts are allowed, they do not contribute to the decision of cell death,954
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but are still observed as contacts in the analysis of the data. After expiration of Tdeath, the dying955
cell disappears from the simulation.956
The ABM is embedded in a user-friendly interface (Figure 3.3) through which the parameter957









Figure 3.3: Agent-based model interface: (a) Datasets and experimental values taken from experi-
mental data, (b) Parameters about general system settings, (c) Hypothesis dependent parameters,
(d) Parameters based on the type of output the user wants.
3.5 Finding Best Parameter Sets959
Although most parameters are taken directly from data, each hypothesis contains a set of associated960
unknown parameters, such as a killing rate or damage rate. Also, Tdeath is unknown. The unknown961
parameters associated with each hypothesis are:962
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1. Null hypothesis: Probability of death at each contact (p0).963
2. Infected cell contact integration: Probability of infected cells getting killed at first contact964
with CTLs (kI).965
3. CTL contact integration: Probability of CTLs killing infected cells at first contact with CTLs966
(kT).967
4. Constant damage: Damage rate (d).968
5. Saturated damage: (i) Damage rate (d); (ii) Maximum time until which CTLs can damage969
infected cells (Tmax).970
6. Damage and repair: (i) Damage rate (d); (ii) Repair rate (r).971
The total cost is derived from the simulation of 8 experimental readouts at the same time (see972
Figure 3.4):973
1. Observed probability of killing infected cells with a particular number of interactions with974
CTLs (Figure 3.4a). In the model, the number of infected cells that died at exactly the ith975
interaction is normalized by the total number of infected cells with at least i interactions.976
2. Distribution of the observed time between first CTL contact and the observed time of cell977
disruption (Figure 3.4b). In the model, this distribution is obtained by monitoring all cells978
from their first contact to a CTL, counting the number of killed cells in time bins, and979
normalising these with the total number of killed infected cells.980
3. Distribution of the number of contacts with CTLs for infected cells that died during the981
observation period (Figure 3.4c). In the model, the number of CTL contacts is saved with982
each cell and a histogram is generated at the end of the simulation and normalized with the983
total number of dead cells at the end of the simulation984
4. Distribution of the number of contacts with CTLs for infected cells that survived the obser-985
vation period (Figure 3.4c). In the model, same procedure as in point 3 is used but for cells986
alive at the end of the simulation.987
5. Total duration of contact with CTLs for infected cells that died during the observation period988
(Figure 3.4d). In the model, each cell in contact to CTL increases a clock and a histogram989
on time bins is generated at the end of the simulation and normalized by the total number990
of dead cells at the end of the simulation.991
6. Total duration of contact with CTLs for infected cells that survived the observation period992
(Figure 3.4d). In the model, same procedure is used as in point 5 but for cells alive at the993
end of the simulation.994
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7. Distribution of single CTL contacts duration for infected cells that died during the observa-995
tion period (Figure 3.4e). In the model, at each contact with CTLs a clock is running and996
the time when the cells detach is saved. For all dead cells, these times are recollected in a997
histogram on time bins at the end of the simulation and normalized with the total number998
of contacts of all dead cells.999
8. Distribution of single CTL contacts duration for infected cells that survived the observation1000
period (Figure 3.4e). In the model, same procedure as in point 7 but for cells alive at the1001
end of the simulation.1002
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Alive infected cells
Killed infected cells
Figure 3.4: Experimental readouts used to compare experimental data [111] with model data: (a)
Probability of killing infected cells with increasing number of interactions with CTLs, (b) Observed
time between first CTL contact and cell death for killed infected cells, (c) Number of contacts with
CTLs for infected cells, (d) Total duration of contact with CTLs for infected cells, (e) Single CTL
contacts duration for infected cells.
When comparing different parameter sets, the formula in equation (3.5) is used to compute the1003











where Cx is the average cost of the x
th dataset, n is the total number of simulations run for each1005
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parameter set, Nx is the total number of data points of the x
th experimental dataset, Ex,i is the i
th
1006
data point of the xth experimental dataset and Mx,i is the i
th data point of the xth model dataset1007
with this parameter set. The subscript x represents the 8 datasets described above.1008
The 8 separate costs were averaged to compute the mean cost (C) for a particular parameter1009







where e is the total number of datasets (e = 8 in the current study) and Cx is the average cost1011
of the xth dataset using equation (3.5).1012
For each hypothesis, the average costs are plotted in a heatmap comparing different combination1013
of parameter values. Then, the parameter set with the lowest cost for each hypothesis was used to1014
run the simulation to get the results. For the first dataset (Figure 3.4a), since the experimental data1015
points beyond the 6th contact only represent a small number of cells, only the 6 first interactions1016
are included in the cost calculation.1017
As all of the hypotheses do not have the same number of unknown parameters, I also computed1018
the Akaike information criterion (AIC) for all the hypotheses using the following formulae:1019
AIC = 2k + sln(C) (3.7)
where k is the number of unknown parameters, s is the number of experimental readouts that are1020
compared with the model readouts and C is the cost. A lower AIC value indicates a better fit of1021
model with experimental data.1022
3.6 Table of Parameters Fixed from Data1023
The parameters that are common for all hypotheses such as the number of CTLs and infected cells1024
are taken from experimental data. These parameter values are tabulated in Table 3.1.1025
3.7 Summary1026
To find out which killing mechanisms can explain the in vivo observed quantitative killing properties1027
observed in [111], I used the ABM described in this chapter. The ABM simulates the movement and1028
interactions of CTLs with non-motile infected cells in 3D as in vivo imaging experiments in [111]1029
(Figure 3.1a). In short, CTLs move in a straight line at a certain speed until a persistence time is1030
reached, and then, a new direction is selected based on the experimentally measured turning angle1031
distribution (Figure 3.1e) and a new speed is selected from the distribution in Figure 3.1d. CTLs1032
and infected cells initiate an interaction with each other, when they reach a threshold distance1033
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Parameter Value
Number of CTLs (NT) 200
Number of infected cells (NI) 250
Percent of z-axis occupied by infected cells (Zlim) 40%
Radius of CTLs (RT) 4.8 µm
Radius of infected cells (RI) 5.1 µm
Interaction Confinement Factor (ICF) 1.5
Collision Confinement Factor (CCF) 0.5
Persistent time (Tpers) 2 minutes
X-axis dimension of space (Xdim) 700 µm
Y-axis dimension of space (Ydim) 700 µm
Z-axis dimension of space (Zdim) 700 µm
Simulation (TSim) 240 minutes
Speed Taken from distribution (Figure 3.1d)
Turning angle Taken from distribution (Figure 3.1e)
Interaction duration Taken from distribution (Figure 3.1f)
Table 3.1: Parameter values taken from experimental data [111]
(Figure 3.1c). The duration of an interaction is directly taken from experimental data shown in1034
Figure 3.1f.1035
The various killing hypotheses outlined in this chapter were tested (Figure 3.2). These include1036
a constant killing rate (Null hypothesis) as seen in Figure 3.2a, a modulated killing capacity of1037
CTLs with interactions as seen in Figure 3.2b, an increased susceptibility of death of infected cells1038
at higher CTL contacts (infected cell contact integration) as seen in Figure 3.2c, and finally a1039
damage rate of infected cells at each contact with CTLs (damage), possibly with repair of the cell1040
(damage and repair) and with a maximal damage per contact (saturated damage) as seen in Figure1041
3.2d. The datasets used to discriminate between killing hypotheses are taken from [111] and are1042
shown in Figure 3.4.1043
Chapter 41044
Results From The Agent Based1045
Model1046
Using the ABM described in the previous chapter, I ran simulations for the killing hypotheses and1047
compared them with the observed experimental data.1048
4.1 Best Parameter Set1049
In the ABM, most of the parameters have been taken directly from experimental data (Section 3.6).1050
But the parameters associated with each hypothesis and the time between activation of apoptosis1051
and visual cell dissolution remained to be estimated (Tdeath). I ran simulations and then computed1052
the cost for all observed 8 datasets from the experiments (equation (3.5)). Using these 8 costs1053
from all datasets, I computed the average costs (equation (3.6)) for all hypotheses in absence of1054
zombie contacts (Figure 4.1) and in presence of zombie contacts (Figure 4.2). The parameter set1055
with the lowest cost has been marked with an ‘X’. The heatmaps show that only a restricted range1056
of parameters is consistent with the observed experimental data.1057
For the identified parameter sets, I ran simulations and plotted the data to compare model1058
results with experimental data. Additionally since the number of unknown parameters is not the1059
same for all hypotheses, I computed the Akaike information criterion (AIC) (equation (3.7)).1060
4.2 Null Hypothesis1061
First, I investigated whether the observed properties of CTL-mediated killing seen in quantitative 2-1062
photon imaging (Figure 3.4) could be explained by a contact history independent killing mechanism1063
(Null hypothesis).1064
For the Null hypothesis, the parameter associated with the hypothesis is the probability of1065
61
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Figure 4.1: Heatmaps for all hypotheses in absence of zombie contacts. (a) Null hypothesis; (b)
CTL contact integration hypothesis; (c) Infected cell contact integration hypothesis; (d) Constant
damage hypothesis; (e) Saturated damage hypothesis; (f) Concomitant damage and repair hypoth-
esis. Each point on the heatmap is obtained by calculating the average cost over 30 simulations for
the respective parameter combination. ‘X’ represents the parameter combination with the lowest
cost. For saturated damage hypothesis and damage and repair hypothesis, there are three variable
parameters and the lowest costs were found scanning the 3D parameter space (data not shown).
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Figure 4.2: Heatmaps for all hypotheses in presence of zombie contacts. (a) Null hypothesis;
(b) CTL contact integration hypothesis; (c) Infected cell contact integration hypothesis; (d) Con-
stant damage hypothesis; (e) Saturated damage hypothesis; (f) Concomitant damage and repair
hypothesis. The heatmaps are obtained using the same conditions described in Figure 4.1
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CTLs killing infected cells. I obtained the best parameter from the heatmap (Figure 4.1a) and1066
subsequently ran simulations for these parameter values (Figure 4.3, green lines).1067
In this model, the observed probability of killing infected cells with increasing interactions1068
remains constant with increasing interaction numbers, as logically expected. The observed constant1069
probability of killing at each contact is in disagreement with the experimental results. The testing1070
of the Null hypothesis thus serves to verify the correctness of the model and confirms that the1071
observed killing probability of infected cells with increasing interactions reflects the CTL-mediated1072
mechanism of cell killing mediated in this context. Moreover, the result obtained shows that1073
a killing probability independent of the contact history can not be a potential mechanism for1074
explaining the in vivo datasets of Halle et al [111].1075
4.3 Contact Integration Hypotheses1076
4.3.1 CTL Contact Integration1077
In order to explain the increase in observed probability of killing infected cells with increasing in-1078
teractions with CTLs (Figure 3.4a), I hypothesized that this could be a consequence of modulation1079
of CTL killing capacity after each interaction with an infected cell. In this hypothesis, CTLs kill1080
with a linearly increasing probability proportional to the number of target cell contacts the CTL1081
had before. The cost of various parameters was plotted using heatmaps and an optimal set of1082
parameters has been determined (Figure 4.1b).1083
For the obtained optimal parameter set, the observed probability of killing infected cells with1084
increasing interactions with CTLs (Figure 4.3a, blue line) along with the corresponding plots for1085
the other datasets (Figure 4.3b-h, blue lines) showed a good agreement of the model results with1086
the experimental results. This indicates that a modulation of CTL killing capacity could be a1087
potential mechanism that can reproduce the experimental observations.1088
4.3.2 Infected Cell Contact Integration1089
Next, I explored whether virus-infected cells might get more susceptible to death with increasing1090
numbers of CTL contacts (infected cell contact integration hypothesis). As opposed to the previous1091
hypothesis, here the infected cells retain memory of prior interactions with CTLs. In this scenario,1092
the death susceptibility of infected target cells was modelled as a linearly increasing probability of1093
death that is proportional to prior number of CTL visits (see Chapter 3). The simulation with the1094
best parameter set (Figure 4.3, red lines) is in agreement with experimental data suggesting that1095
infected cells may get more susceptible to cell death with increasing number of CTL contacts.1096
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Figure 4.3: Plots for optimal parameters for all hypothesis in absence of zombie contacts. (a)
Observed probability of killing infected cells in dependence on the number of interactions with
CTLs, (b) distribution of observed times between first contact to a CTL and actual cell death for
all killed infected cells, (c) distribution of the number of contacts with CTLs for all infected cells
that survived during the observation period and, (d) were killed during the observation period,
(e-h) distribution of total (e, f) and single (g, h) contact durations with CTLs for infected cells
that survived during the observation period (e, g) and were killed during the observation period
(f, h). Error bars represent SD from 30 simulations.
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4.4 Damage-Based Hypotheses1097
In the previous hypothesis, I established that infected cells retaining memory of contacts with1098
CTLs could be a potential mechanism. Next, I explored the mechanisms through which infected1099
cells could retain memory of previous CTL contacts. I hypothesized that infected cells get damaged1100
by interacting CTLs and once the damage of an infected cell reaches a threshold value of 1, the cell1101
dies. The three damage-based hypotheses that were considered were constant damage, saturated1102
damage, and damage and repair hypothesis (Figure 3.2d).1103
The constant damage hypothesis involves a constant rate of damage during interactions. In1104
the saturated damage hypothesis, the damage process by the CTL halts after the duration of the1105
ongoing interaction exceeds a threshold time (Tmax). This hypothesis was proposed because CTLs1106
have a storage of cytolytic granules and are potentially unable to sustain a damage process for1107
very long interactions, reaching up to 40 minutes in the in vivo dataset. Therefore, a possible1108
biological factor that affects the killing observations could be T cell exhaustion during a single1109
contact if the contact exceeds a certain threshold duration. I proposed that the interlude between1110
two consecutive contacts is long enough for the CTLs to recuperate and be able to damage the1111
infected cells again. In the damage and repair hypothesis, there is no T cell exhaustion. The CTLs1112
damage the infected cells throughout the duration of the interaction and the infected cells also1113
repair themselves. The repair mechanism continues irrespective of an ongoing interaction or even1114
if the infected cell is not interacting at a given time.1115
I was able to reproduce the increasing probability of killing infected cells with increasing inter-1116
actions with CTLs (Figure 4.3a, orange and grey lines respectively) for constant damage (Figure1117
4.1d) and saturated damage hypothesis (Figure 4.1e). Further calculations for both hypotheses1118
show that the plot for observed time between the first contact to a CTL and the actual cell death1119
obtained from the model does not coincide with the experimental distribution (Figure 4.3b, orange1120
and grey lines respectively).1121
The best parameter set identified from the heatmap shows a damage rate of around 0.03 per1122
minute for constant and saturated damage hypotheses (Figure 4.1d, e). For a cell to get a damage1123
of 1, a total contact time of 1/d minutes is required (see Chapter 3). For a value of d = 0.031124
per minute, the total contact time required for a damage of 1 is ∼ 33.3 minutes which is also the1125
minimum time a cell will take to die after the first observed CTL contact provided that the time1126
between the fate decision for death and the actual dissolution of the cell is negligible. For the1127
saturated damage hypothesis, the value would exceed ∼ 33.3 minutes (see Chapter 3). For the1128
damage and repair hypothesis, the optimal value for damage is 0.03 per minute and the value for1129
repair is 0.009 (Figure 4.1f). The duration of one contact that is enough to induce a total damage1130
of 1 is ∼ 39.6 minutes (see Chapter 3). For an infected cell that dies, the observed time between1131
the first contact with a CTL and the actual cell death will also consists of the time that passes1132
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between consecutive contacts. As shown by the calculations above, for all of the damage-based1133
hypothesis, no infected cell can die before an observed time of 30 minutes or less between the first1134
CTL contact and cell death which is in disagreement with the experimental data (Figure 4.3b,1135
pink line). All of the damage-based hypotheses that we described above have a constant rate of1136
damage. Thus, I concluded that none of the damage-based hypotheses with a constant damage1137
rate are compatible with all the experimental datasets.1138
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Figure 4.4: Impact of zombie contacts on model selection. Same as Figure 4.3 using the best fitted
parameters (Figure 4.2) for each hypothesis in presence of zombie contacts. Error bars represent
SD from 30 simulations
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4.5 Zombie Contacts1139
4.5.1 Null Hypothesis1140
It is interesting to note that for all of the hypotheses above, the value of Tdeath is non-zero. The1141
theory that an infected cell persists in the system in a state of activated apoptosis led me to explore1142
the impact of contacts between CTLs and apoptotic infected cells. Thus, a target might receive1143
multiple CTL contact events, even though the fate decision to die has already been made. It has1144
been observed that once a target cells is disrupted, the remaining small so-called remnants of the1145
target cells are only sometimes contacted by CTLs. A possible explanation could be that most1146
of these remnants are taken up by local dendritic cells and macrophages, thus preventing direct1147
access of the CTLs to the membrane or the remnants.1148
It is unknown how CTL interactions with target cells in the process of cytolysis might affect CTL1149
killing mechanisms and estimates of CTL killing efficiency. To address this question, I next tested1150
whether the allowance of “zombie contacts” impacts the observed probability of killing infected1151
cells with increasing interactions with CTLs. I used the term “zombie contacts” to illustrate1152
the interaction of a CTL with a target cell for which the intracellular pro-cell death signalling1153
mechanisms have already passed a non-reversible cell death pathway checkpoint. Importantly,1154
even the use of caspase reporter activity does not yet allow such data to be generated in vivo,1155
therefore I used my agent-based model to better understand the possible impact of such zombie1156
contacts.1157
Simulations with the Null hypothesis with zombie contacts were performed with different killing1158
probabilities and Tdeath distributions (Figure 4.2a). An optimal parameter set could be identified,1159
and the simulations for each separate dataset are shown (Figure 4.4a-h, green lines). Strikingly,1160
although CTLs mechanistically kill with equal probability at each contact in the model under1161
the Null hypothesis, the probability of killing infected cells shows an increase with increasing1162
interactions with CTLs, in the presence of zombie contacts (Figure 4.4a, green line).1163
Due to zombie contacts, when following CTL killing activity in vivo, the time during which cells1164
are already dying is counted in the analysis of the number of contacts. A consequence of counting1165
these zombie contacts is that it leads to an over-estimation of number of contacts compared to1166
the real number of contacts that lead to cell death. Thus, I showed that the zombie contacts1167
have a significant impact on the probability of killing infected cells with increasing interactions1168
with CTLs in case of a Null hypothesis. Consequently, the hypothetical possibility of zombie1169
contacts introduces another uncertainty into the analysis of live-imaging data. An increase in1170
probability of killing infected cells with increasing interactions with CTLs does not necessarily1171
reflect a modulation of the CTL killing efficiency at the cellular level but could be an artefact that1172
arises due to the presence of zombie contacts.1173
Interestingly, the Null hypothesis in the presence of zombie contacts is compatible with all other1174
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datasets (Figure 4.4b-h, green lines). Even though, constant probability of killing at each contact1175
can explain all datasets, there is an underlying assumption that zombie contacts do take place,1176
and that the time to die would actually last 25 minutes (Figure 4.2a). In addition, after the 6th1177
contact, the simulations show a saturation in the probability of killing infected cells with increasing1178
interactions with CTLs while the experimental dataset continues increasing. Eventually, a longer1179
observation time would increase the total number of observed contacts per target cells and allow1180














































































Figure 4.5: Comparison of AIC values for all hypotheses corresponding to their respective least
cost. The data points in blue show the hypotheses that gave a good agreement with experimental
results. The data points in orange show the hypotheses that were rejected.
4.5.2 Effect of Zombie Contacts1182
Considering the observed impact of zombie contacts in the Null hypothesis, I revisited all other1183
hypotheses to test whether addition of zombie contacts to the ABM changes model performance1184
in other scenarios as well (Figure 4.4b-f). In presence of zombie contacts, CTL contact integration1185
and infected cell contact integration gave results in agreement with the experimental results but1186
none of the damage-based hypotheses gave rise to plots that were in agreement with the experi-1187
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Figure 4.6: (a, b) PCKR values for variable number of infected cells (a) and of CTLs (b), (c,
d) Fraction of killed cells for variable number of infected cells (c) and of CTLs (d). Error bars
represent SD from 30 simulations.
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Hypothesis Killing parameter Tdeath Least cost AIC
Infected cell contact integration 0.09 15 4.35 ∗ 10−3 -39.5
CTL contact integration 0.008 10 4.70 ∗ 10−3 -38.9
Null hypothesis 0.2 15 7.35 ∗ 10−3 -35.3
Damage 0.03 35 9.37 ∗ 10−3 -33.3
Damage and repair d=0.03, r=0.009 40 8.60 ∗ 10−3 -32.0
Saturated damage d=0.03, Tmax=20 35 8.64 ∗ 10−3 -32.0
Table 4.1: Least cost for all Hypotheses in absence of zombie contacts in ascending order of AIC
Hypothesis Killing parameter Tdeath Least cost AIC
Infected cell contact integration 0.18 35 3.12 ∗ 10−3 -42.1
Null hypothesis 0.35 25 3.41 ∗ 10−3 -41.4
CTL contact integration 0.014 10 3.90 ∗ 10−3 -40.4
Saturated damage d=0.06, Tmax=10 15 5.01 ∗ 10−3 -36.4
Damage 0.03 35 6.82 ∗ 10−3 -35.9
Damage and repair d=0.04, r=0.02 5 6.83 ∗ 10−3 -33.9
Table 4.2: Least cost for all Hypotheses in presence of zombie contacts in ascending order of AIC
mental results. This implies that apart from the Null hypothesis, the observed behaviour of the1188
system remains the same irrespective of the presence or absence of zombie contacts. Note that all1189
hypotheses showed a lower cost and a lower Akaike information criterion (AIC) value in presence1190
of zombie contacts than in absence of zombie contacts as shown in Table 4.1 and Table 4.2 (Figure1191
4.5). This shows that the inclusion of zombie contacts gives rise to a better fit with experimental1192
data.1193
4.6 Discriminating Between Best Hypotheses1194
4.6.1 Per Capita Killing Rate1195
By selecting the optimal parameter and plotting the readouts obtained from the experiments, var-1196
ious hypotheses were discarded. The five hypotheses that give a good agreement with all datasets1197
in ascending order of cost are: (i) Infected cell contact integration in presence of zombie contacts,1198
(ii) Null hypothesis in presence of zombie contacts, (iii) CTL contact integration hypothesis in1199
presence of zombie contacts, (iv) infected cell contact integration in absence of zombie contacts,1200
and (v) CTL contact integration hypothesis in absence of zombie contacts.1201
Since the datasets were not enough to discern between these five hypotheses, I sought to predict1202
properties of the different hypotheses that could further help to discriminate them or to design1203
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new predictive experiments. One property is the observed PCKR of CTLs, as a measure of 3D1204
population killing efficiency. The PCKR is defined as the number of infected cells killed per CTL1205
in 24 hours. Another important measure is the fractions of killed infected cells defined as the ratio1206
of killed infected cells to the total number of infected cells in the system.1207
To understand how the number of infected cells affects the PCKR values, the number of CTLs1208
was kept constant at 200 while the infected cell number was varied from 20 to 400 (Figure 4.6a). The1209
other parameter values were kept fixed at the optimal parameter set obtained from the respective1210
cost heatmaps of each hypothesis. For all five hypotheses, the values of PCKR increased with1211
increasing number of infected cells however the increase was highest for the Null hypothesis.1212
Next, to elucidate the effect of the number of CTLs on the PCKR, the number of infected1213
cells was kept constant at 250 while the CTL numbers were varied from 20 to 400 (Figure 4.6b).1214
Surprisingly, even when the ratio of infected cells to CTLs is high, the values of PKCR remained1215
constant for all hypotheses except the Null hypothesis where I saw a small drop in values of PCKR1216
with increasing number of CTLs.1217
4.6.2 Fraction of Killed Infected Cells1218
Using the simulations describes above, I looked at the fraction of infected cells that are killed by1219
CTLs for cases with different number of initial infected cells. A surprising result that is observed is1220
that even for a low number of infected cells, CTLs fail in killing all infected cells within the 4-hour1221
time window that is being analyzed (Figure 4.6c). In addition, while the fraction of cells killed1222
showed a drop in values for Null hypothesis and infected cell contact integration hypothesis in1223
presence and absence of zombie contacts, an increase in values is seen for CTL contact integration1224
hypothesis in presence and absence of zombie contacts.1225
In contrast to the results obtained for variable number of infected cells, it is observed that1226
for all four hypotheses, the fraction of infected cells killed increases with number of CTLs and at1227
a higher number of CTLs, a much larger fraction of infected cells is killed (Figure 4.6d). Taken1228
together, these results suggest that by keeping all other factors of a system constant and varying1229
either the number of infected cells or the number of CTLs, we can differentiate between different1230
killing hypotheses using PCKR and fraction of killed cells analysis.1231
4.7 Summary1232
The results obtained from the ABM show that retention of information about prior contacts by1233
CTLs or infected cells, could be a phenomenon that explains all the observed datasets. A surprising1234
result is that in the presence of contacts between dying infected cells and CTLs (zombie contacts)1235
a contact history independent killing can give rise to an increase in the observed probability of1236
killing infected cells with increasing interactions with CTLs. Interestingly, none of the linear1237
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damage based hypotheses were consistent.1238
In general, I showed that only one dataset is not enough to discriminate hypotheses, but1239
rather their combination. In the rejected hypotheses, the parameter sets that are consistent with1240
one dataset are not consistent with the other one. Thus, in order to discriminate between the1241
proposed hypotheses, all the datasets are important and need to be analyzed. I also proved that1242
the hypotheses that work do so only for a short range of values, implying that for each successful1243
hypothesis, the killing rates could be identified. Using a heatmap to find the best parameter range,1244
even the values of the time to die Tdeath could be identified which is an important hidden biological1245
parameter.1246
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Chapter 51247
Impact of Temporal Factors on1248
Observed Results1249
In Chapter 2, I proposed a way to analyse the experimental data in [111] such that it accurately1250
represents the killing properties of CTLs and is time independent. The PTA as I established can1251
be employed to understand the dynamics of various systems that adhere to a certain set of rules1252
that I have described in detail. The agent based model that I described in Chapter 3 can serve1253
as a low cost and time efficient way to apply the PTA and to confirm if it gives expected results.1254
Additionally, the ABM and PTA together can be used to understand the significance of observed1255
properties for systems.1256
5.1 Constant System: Ratio of Killed Target Cells at Each1257
Contact to Total Cells at Each Contact vs PTA1258
As discussed in equation (2.1), the equation for the ratio of killed target cells at each contact to1259










To compare the differences between the results obtained by the methods of analysis outlined in1262
equations (5.1) and (5.2) respectively, I analyzed observed data using these equations. As described1263
in Chapter 2, I wanted to confirm whether the application of PTA to the Null hypothesis gives the1264
same result for varying observation time windows.1265
75
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To do so, I used the agent-based model described in Chapter 3 with the Null hypothesis.1266
As discussed in Section (3.4), the probability of CTL mediated infected cell killing (p0) remains1267
constant as the number of CTL contacts increases in Null hypothesis. Thus, an observed change in1268
calculated values will be a consequence of factors other than system dynamics. I ran simulations1269
for the Null hypothesis with the probability of killing infected cells, p0 as 0.2. I ran two simulations,1270
one for a time of 120 minutes and another for 360 minutes respectively and analyzed the data using1271
both methods of analyses (Figure 5.1a, b).1272
The plots obtained using the analysis method defined in equation (5.1) show a difference be-1273
tween observed killing frequencies when observed for different time windows. The plot for a longer1274
time window shows a higher ratio of killed target cells at each contact to total target cells at each1275
contact in comparison to the shorter time window. Another drawback of the method is that for1276
either of the time windows, I am unable to obtain values for the probability of dead cells that1277
accurately reflect the values that were input into the system. In this case, the value for cell death1278
probability is p0 at each contact. The value of p0 was set to 0.2 but the values obtained from the1279
observations are 0.3 and 0.4 for different time windows. On the other hand, the plots obtained by1280
analysing the data using the new proposed method of analysis in equation (5.2) show no difference1281
in values for different time windows. In addition to that, the values obtained from the analysis1282
show a good agreement between the input and the observed value of p0 = 0.2.1283
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Figure 5.1: Comparison of data analysis methods for null hypothesis: (a) The ratio of killed target
cells at each contact to total target cells at each contact for varying observation times gives a
variation in results, (b) Observed probability of killing infected cells gives same values for both
observation windows. Error bars represent SD from 50 simulations.
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5.2 Application of PTA on Different Killing Hypotheses1284
Having established that the PTA gives a result that is not dependent on the duration of the obser-1285
vation window for the Null hypothesis, I investigated if the analysis gives a result that accurately1286
describes the observed dynamics of the system.1287
I ran simulations for varying values of the p0, kT and kI respectively for the three killing1288
hypotheses described by Null hypothesis, CTL contact integration and infected cell contact inte-1289
gration. p0 is the killing probability at each contact for the Null hypothesis, kT is the probability1290
of a CTL killing an infected cell at the first contact in CTL contact integration hypothesis and1291
kI is the probability of an infected cell getting killed at the first contact in infected cell contact1292
integration hypothesis. I plotted the ratio of killed target cells at each contact to total cells at each1293
contact (Figure 5.2 a-c) and the PTA values for all three hypotheses (Figure 5.2 d-f). The plots for1294
the ratio of killed target cells at each contact to total cells at each contact for all three hypotheses1295
show a difference for different parameter values but as discussed above, it is not possible to recover1296
the values of probability of cell death after getting the ith contact with a CTL (pi) from these1297
plots.1298
For all three killing hypotheses, the plots show dynamics that are easily distinguishable for1299
varying parameter values (Figure 5.2 d-f). It is interesting to note that the plots for CTL contact1300
integration killing hypothesis and infected cell contact integration killing hypothesis give rise to1301
similar plots that show an increase in observed probability of killing infected cells with increasing1302
number of contacts with CTLs (Figure 5.2e, f). An increase in CTL efficiency with increasing1303
interactions (Figure 5.2e) and an increase of infected cell susceptibility (Figure 5.2f) to cell death,1304
both show similar dynamics of an increase in the observed probability of killing infected cells with1305
increasing CTL interactions. This implies that while the PTA can help differentiate the dynamics1306
of the system, it cannot be used to know what causes the change in dynamics.1307
5.3 Varying Observation Times1308
A limitation of experimental systems is that the duration of observation window could vary. The1309
same system under observation for varying time periods could show different results that could arise1310
due to the difference in dynamics at a given time. Using PTA, I explored how various temporal1311
variations in experimental systems affect the observations of various killing hypotheses.1312
Using the agent based model, I ran simulations for the (i) Null hypothesis; (ii) CTL contact1313
integration; and (iii) infected cell contact integration. For each of these, I ran simulations for1314
varying observation duration windows of 240 minutes, 360 minutes and 480 minutes and plotted1315
the ratio of killed target cells at each contact to total cells at each contact (Figure 5.3 a-c) and the1316
PTA values for all three hypotheses (Figure 5.3 d-f). For each of the hypothesis, I ran simulations1317
78 CHAPTER 5. IMPACT OF TEMPORAL FACTORS ON OBSERVED RESULTS
a b c



















































































































































































































































































































Figure 5.2: Computing the ratio of killed target cells at each contact to total cells at each contact
and PTA to different killing hypotheses for varying parameter values for Null hypothesis for vary-
ing values of killing probability at each contact (p0), CTL contact integration killing hypothesis
for different probability of killing at first contact (kT) and infected cell contact integration killing
hypothesis for different probability of getting killed at first contact (kI). The ratio of killed tar-
get cells at each contact to total cells at each contact for (a) Null hypothesis, (b) CTL contact
integration killing hypothesis, (c) Infected cell contact integration killing hypothesis. PTA plots
for (d) Null hypothesis, (e) CTL contact integration killing hypothesis, (f) Infected cell contact
integration killing hypothesis. Error bars represent SD from 50 simulations.
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from the optimal parameter values obtained in Chapter 4.1318
It is interesting to note that while the plots for the Null hypothesis do not show a difference1319
for varying time windows, the same cannot be said for CTL contact integration or infected cell1320
contact integration killing hypotheses. In the case of both the contact integration hypotheses, the1321
system evolves as a consequence of increasing interactions. The number of interactions that the1322
cells get changes with time. Hence, the system evolves with time. At two separate times, the1323
population of infected cells will show different behavior in case of infected cell contact integration1324
and the population of CTLs will show different behavior in case of CTL contact integration killing1325
hypotheses. Thus, the PTA analysis gives different values at different times for systems whose1326
properties evolve with time.1327
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Figure 5.3: Varying observation windows to calculate the ratio of killed target cells at each contact
to total cells at each contact and PTA to different killing hypotheses for Null hypothesis, CTL con-
tact integration and infected cell contact integration. The ratio of killed target cells at each contact
to total cells at each contact for (a) Null hypothesis, (b) CTL contact integration killing hypothe-
sis, (c) Infected cell contact integration killing hypothesis. PTA plots for (d) Null hypothesis- The
plots for varying observation windows are the same, (e) CTL contact integration killing hypothe-
sis, (f) Infected cell contact integration killing hypothesis- The observed dynamics for the window
of 0-240 minutes versus 0-480 minutes shows a significant difference (p-value=0.036). Error bars
represent SD from 50 simulations.
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5.4 Impact of Unknown History on Observed Results1328
Another temporal factor that affects the observed results is that experimental systems could have1329
a history associated with them. Thus, in the system described in [111], the infected cells could1330
already have had contacts with CTLs before the experimental observations were recorded.1331
Next, I investigated the effect of an unknown history on the observed plots. I ran the complete1332
simulation for 480 minutes and observed the system for system for 240 minutes. This observation1333
of 240 minutes was initiated at different time points (0 minutes, 120 minutes and 240 minutes).1334
Thus, I compared how an unknown history of a system affects the plots obtained for the ratio of1335
killed target cells at each contact to total cells at each contact (Figure 5.4a-c) and PTA (Figure1336
5.4d-f). Here I study how knowing the complete history (0 to 240 minutes) compares to having1337
unknown history (120 minutes to 360 minutes and 240 minutes to 480 minutes).1338
It is interesting to note that for the Null hypothesis where the CTLs kill with an equal prob-1339
ability at each CTL-target cell contact, an unknown history does not affect the observed killing1340
dynamics of the system (Figure 5.4d). That is due to the fact that the system does not evolve with1341
time and the properties remain constant. On the other hand, for CTL contact integration and1342
infected cell contact integration, the systems evolve with time and at a later time point, the system1343
consists of more efficient CTLs and more susceptible infected cells respectively (Figure 5.4e, f).1344
The value obtained from the PTA equals pi (refer to Chapter 2, Table 2.1). For the case of Null1345
hypothesis, the value of pi remains unchanged with contacts but for CTL contact integration and1346
infected cell contact integration, the value of pi changes with contacts. Thus, as time progresses1347
and CTLs and infected cells more contacts, the value of pi for the cell population changes. Addi-1348
tionally, while the plots are different for the cases with unknown history and the complete known1349
history, the plots do not show a significant difference for varying duration of unknown history for1350
infected cell contact integration hypothesis (p-value=0.059). The system exhibits similar dynamics1351
for an unknown history of 120 minutes and 240 minutes. This shows that in order to be able to1352
compare two systems, it is important to start the observations at the same time to avoid any bias1353
in results due to unknown history.1354
5.5 Summary1355
The PTA analysis for CTL mediated killing gives the probability of infected cell death at each1356
contact. By comparing the plots for the ratio of killed target cells at each contact to total cells at1357
each contact and PTA for Null hypothesis, I show that the PTA returns the value of pi input into1358
the system.1359
With the knowledge that PTA precisely represents the probability of killing infected cells at1360
each contact, I could explore the impact of varying observation duration and unknown history on1361
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Figure 5.4: Varying unknown history duration to calculate the ratio of killed target cells at each
contact to total cells at each contact and PTA to different killing hypotheses for Null hypothesis,
CTL contact integration and infected cell contact integration. The ratio of killed target cells at
each contact to total cells at each contact for (a) Null hypothesis, (b) CTL contact integration
killing hypothesis, (c) Infected cell contact integration killing hypothesis. PTA plots for (d) Null
hypothesis, (e) CTL contact integration killing hypothesis, (f) Infected cell contact integration
killing hypothesis. Error bars represent SD from 50 simulations.
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observed killing dynamics. In systems where the value of probability of infected cells to get killed at1362
each contact varies with the number of contacts, the PTA gives rise to different results at different1363
times. This result confirms that the PTA accurately gives the killing dynamics at different time1364
points.1365
The varying PTA values obtained for varying time windows and unknown history also establish1366
the futility of comparing two different experimental setups for the same system at different times.1367
It also indicates that experiments involving CTL mediated killing should be planned to ensure that1368




T cell activation, as discussed in Chapter 1, takes place in the lymph node by forming transient1373
and stable interactions between APCs and T cells. In 2015, Dong et al [114] showed that T cell1374
motion changes as a consequence of antigen affinity. At steady state, T cells had high velocities and1375
relatively persistent trajectories similar to amoeboid migration. In presence of low affinity antigen,1376
T cells exhibit a switching migration mode that gives rise to T-cell exploratory behavior by means1377
of partial deceleration and frequent direction changes. On the other hand, in the presence of high1378
affinity antigen, T cells show pronounced deceleration. Whether the motion behaviour of T cells1379
shows a gradual change with increasing signal integration still remains to be explored. To this1380
end, Mayya et al studied the motion properties of T cells when they are getting activated. In this1381
chapter, I have analyzed the motility properties of T cells with time and I have also studied the1382
impact of increasing number of kinapses on the speed and turning angle.1383
Additionally, using PTA (refer to Chapter 2), I have computed the probability of T cell per-1384
manent arrest with increasing number of kinapses. I did this for different antigen concentrations,1385
allowing me to explore the impact of antigen concentration on T cell arrest.1386
6.2 Methods1387
The lymph node is a dynamic, 3D environment and the study of kinapses and synapses proved to1388
be difficult in vivo due to internal tissue movement and limitations of 3D rendering. To this end,1389
in 2018, Mayya et al. used a system to observe the properties of T cell interactions with T cell1390
receptor stimuli such that it was free of other influences that arise in an in vivo setup [207]. The1391
system involved studying the behavior of freshly isolated human and mouse T cells. These T cells1392
were introduced on a glass surfaces consisting of 2D stimulatory surfaces (Figure 6.1). The 2D1393
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stimulatory spots, which were equally distributed along length and breadth of the glass surface were1394
circular in shape. The radius of each antigen spot was 5 µm and the distance between the centres1395
of each antigen spot was 30 µm. They were uniformly coated with ICAM1 and Okt3 antibody. The1396
ICAM1 is an adhesion molecule whereas the anti-CD3 molecule interacts with antigen receptors1397
associated with CD3 molecular complex on T cell surface to induce T cell activation [208]. This1398
system is a general representation of the spatially uniform presentation of antigen to T cells by1399
the dendritic cell network as seen in vivo. Using this setup, the motion properties of T cells were1400
tracked for 2 hours. The experiment was done for three antigen concentrations on the spot: 11401
µg/ml, 2 µg/ml and 4 µg/ml. As a control, one experimental setup also included the isotype1402
(iso) antibody which does not trigger the TCR. This is a good control for confirming the temporal1403
evolution of the system due to intermittent signaling.1404
At any given point in the experiment, prior to permanent arrest on the antigen spot, a T cell in1405
motion could exist either in kinapse mode while interacting with an antigen spot or a T cell could1406
be moving in the 2D space in a searching mode. Each of these kinapses are temporary interactions1407
between T cells and antigen that eventually lead up to synapse formation which is the permanent1408
arrest. The data recorded from the experiments consists of the x- and y-coordinate of T cells along1409
with the associated time stamp. Thus, we can use this information to calculate the speed and1410
turning angle of T cells. Since the two states that a T cell can exist in have different motility1411
properties, I used the data obtained from the experimental data to study the impact of increasing1412
number of kinapses with antigen spots on the motility properties of T cells during both phases.1413
The types of experimental data recorded at each time point in the experiments are:1414
1. x- and y-coordinate: The coordinates can be used to calculate the speed and to know if a T1415
cell is arrested.1416
2. IRM attachment area: By making using of interference reflection microscopy (IRM), the area1417
of attachment to the underlying substrate is recorded.1418
Using the above data, the speed over four steps is calculated and compared to the threshold1419
speed (vthreshold). In the same way, the IRM attachment area of the T cell is compared to the1420
IRM attachment area threshold (athreshold). The values for vthreshold and athreshold are based on1421
observations of T cell arrest from experimental data. In this system, vthreshold = 1.5µm/s and1422
athreshold = 5µm
2.1423
The T cells can be in one of three possible states based on their motility properties and the1424
three states can be separated using the coordinates and IRM attachment area values (Table 6.1).1425
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T cell states Speed IRM attachment area
Searching mode No condition < athreshold
Kinapse > vthreshold > athreshold
Arrested < vthreshold > athreshold
Table 6.1: Format of data output of infected cells killed by CTLs
Figure 6.1: The experimental setup to study T cell motion properties consists of 2D stimulatory
surfaces coated with antigen. Figure reproduced from [207].
6.3 Change in T cell Motility Properties Over Time1426
To quantify the change in T cell speed and turning angle over time, I divided the recorded data1427
into time blocks of 20 minutes each. I started this analysis at 50 minutes to rid the analysis of1428
any bias or perturbation caused by the introduction of T cells to the system. For each block of 201429
minutes, I calculated the speed and turning angle using the recorded coordinates and time. These1430
values were then pooled to give the average speed and turning angle (Figure 6.2).1431
There is a drop in the average speed of T cells in all cases except for where there is no antigen1432
(Figure 6.2a). Another salient feature of the plot is that the average speed is lower at higher antigen1433
concentrations (Figure 6.2a). On the other hand, the turning angle does not show a change with1434
time but it is interesting to note that the turning angle is lower for the experiment with no antigen1435
(Figure 6.2b).1436
Based on the patterns that the speed and turning angle follow, I hypothesized that T cells1437
get arrested on the antigen spots as time progresses, leading to a decrease in speed values. To1438
test this, I removed the arrested portions from the recorded data. The portions that remained1439
after removing arrested portions were T cell tracks that were in kinapse or searching mode. Using1440
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these T cell tracks, I repeated the analysis for 20 minutes time blocks (Figure 6.3). In contrast to1441
what was observed previously, on removing the arrested T cell tracks, the average speed of T cells1442
does not show any change with time till nearly 170 minutes. After 170 minutes, the average speed1443
value for T cells shows a decrease for lower antigen concentration but remains the same for higher1444
antigen concentration. Interestingly, the average speed value shows an increase in the absence of1445
antigen. The turning angle, on the other hand, remained constant with time.1446
The average speed values of T cells (Figure 6.2a) for different antigen concentrations show1447
smaller values for higher antigen concentration as time progresses but on excluding the arrested1448
portions, the speed remains the same for all antigen concentrations till 170 minutes (Figure 6.3a)1449
suggesting that the drop in speed observed in Figure 6.2a is a consequence of arrested T cell tracks.1450
Together, Figure 6.2 and Figure 6.3, show that T cells get arrested on antigen spots leading to a1451
decrease in the average speed of the T cell population. A sharper drop in T cells’ speed indicates1452
that a larger number of T cells are arrested on antigen spots. Thus, the results also show that a1453



































































































































50-70 90-110 130-150 170-190 210-230 250-270 50-70 90-110 130-150 170-190 210-230 250-270
Figure 6.2: Motility properties of T cells over 20 minutes time blocks: (a) The speed of T cells
decreases with increasing time, (b) The turning angle does not show significant change over time
but the turning angle is lower for the setup with isotype antibody. Error bars represent SD. Mean
and SD are computed by analysing 7592 cell tracks for 1 µg/ml antigen concentration, 15,288 cell
tracks for 2 µg/ml antigen concentration, 12,313 cell tracks for 4 µg/ml antigen concentration and
14,183 cell tracks for isotype antibody.
6.4 Effect of Increasing Kinapses on T cell Motion Proper-1455
ties1456
The change in speed of T cells in the presence of antigen raised an interesting question about the1457
effect of increasing number of kinapses on motility properties. In the system, as time progresses,1458
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Figure 6.3: Motility properties of T cells over 20 minutes time blocks excluding arrested T cell
tracks: (a) The value of speed for T cells remains constant with time, (b) The value of turning
angle for T cells remains constant with time. Error bars represent SD. Mean and SD are computed
by analysing 7592 cell tracks for 1 µg/ml antigen concentration, 15,288 cell tracks for 2 µg/ml
antigen concentration, 12,313 cell tracks for 4 µg/ml antigen concentration and 14,183 cell tracks
for isotype antibody.
T cells have multiple kinapses with antigen spots. We hypothesized that the motion properties of1459
T cells change as a consequence of signal integration. To test if an increasing number of kinapses1460
have an effect on the motion properties, I used the criteria defined above for kinapses and searching1461
mode to separate the T cell tracks into the two phases. I plotted the T cell speed and turning1462
angle in both phases as a function of the number of kinapses a T cell had had (Figure 6.4).1463
From the plots, it can be seen that neither the speed, nor the turning angles are impacted by1464
the increasing number of kinapses that a T cell has had. These plots deny the presence of signal1465
integration in T cells on the level of motion properties.1466
6.5 Duration of Kinapses1467
The separation of T cell tracks into kinapse and searching mode also gave an insight into the1468
duration of kinapses of T cells with antigen spots. I questioned whether the duration of kinapses1469
changes as a consequence of increasing number of kinapses. I used the T cell tracks to explore the1470
effect of prior kinapses on the duration and plotted the duration of all kinapses as a function of1471
the prior kinapses that the T cell had had (Figure 6.5). The obtained plot shows that the average1472
duration of most kinapses in this setup is in the range of 70 to 90 seconds but the average remains1473
unchanged with time and antigen concentration. Due to the large error bars seen in the plot, I am1474
unable to draw any further conclusion on the effect of increasing number of kinapses on kinapse1475
duration.1476
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Figure 6.4: T cell motion properties as a function of the number of kinapses that the T cell has
had: (a) Speed of T cells in kinapse mode, (b) Turning angle of T cells in kinapse mode, (c) Speed
of T cells in searching mode, (d) Turning angle of T cells in searching mode. Error bars represent
SD. Motion properties during kinapse and searching mode are computed by analysing 7592 cell
tracks for 1 µg/ml antigen concentration, 15,288 cell tracks for 2 µg/ml antigen concentration,
12,313 cell tracks for 4 µg/ml antigen concentration and 14,183 cell tracks for isotype antibody.
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Figure 6.5: Duration of kinapses of T cells as a function of the number of prior kinapses that the
T cell has had. The number of kinapses and SD for each antigen concentration were calculated
by analysing 7592 cell tracks for 1 µg/ml antigen concentration, 15,288 cell tracks for 2 µg/ml
antigen concentration, 12,313 cell tracks for 4 µg/ml antigen concentration and 14,183 cell tracks
for isotype antibody.
6.6 Kinapses Needed for T cell Arrest1477
An interesting feature seen in Figure 6.5 is that while with lower antigen concentrations T cells1478
go on to have more than 10 kinapses, T cells in the presence of 4 µg/ml do not get more than 81479
kinapses prior to synapse formation. This led to a question about the number of kinapses needed1480
before a T cell gets arrested at different concentrations.1481
With information about when T cells are in arrest and the number of kinapses that a T cell has1482
before arrest, I plotted the number of T cells that are arrested as a function of the total kinapses1483
that the T cell had had (Figure 6.6a). I also normalized the number of T cells arrested after each1484
kinapse with all T cells that got permanently arrested by the end of the experiment (Figure 6.6b).1485
An interesting observation from these plots is that a large fraction of T cells needs just one1486
kinapse to get permanently arrested on antigen spots. Another striking observation is that the1487
fraction of cells that get permanently arrested to antigen spots is higher at higher antigen concen-1488
tration values. This suggests that at higher antigen concentrations, T cells accumulate signal more1489
quickly.1490
6.7 Probability of Permanent Arrest1491
On careful consideration of the system described above, it can be seen that it fits into the general1492
framework of a system where the PTA can be applied. As described in Chapter 2, a system needs1493
to consist of a species undergoing an irreversible change as a result of a recurring event. Here the1494
species undergoing a change are the T cells, the recurring events are the kinapses with antigen1495
spots and the irreversible change is T cell arrest on an antigen spot. This reinforces the versatility1496
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Figure 6.6: (a) Number of T cells forming synapses as a function of increasing number of kinapses,
(b) Fraction of T cells forming synapse as a function of increasing number of kinapses. Number of
T cells under permanent arrest as a function of number of kinapses calculated by analysing 7592
cell tracks for 1 µg/ml antigen concentration, 15,288 cell tracks for 2 µg/ml antigen concentration,
12,313 cell tracks for 4 µg/ml antigen concentration and 14,183 cell tracks for isotype antibody.
of PTA and opens up the possibility of exploring the impact of increasing number of kinapses on1497
the probability of T cell arrest on antigen spot.1498





where Ci is the number of elements that transitioned at exactly i recurring events and Si is the1500
number of elements that did not transition at exactly i recurring events. In the current system,1501
Ci are the number of T cells in permanent arrest at exactly i kinapses and Si are the T cells not1502
in permanent arrest after i kinapses.1503
I analysed the experimental data for all three different antigen concentrations (1 µg/ml, 21504
µg/ml and 4 µg/ml) to understand how different antigen concentrations affect the probability of1505
arrest (Figure 6.7).1506
The analysis shows that while an increasing number of transient contacts do not lead to an1507
increase in observed fraction of arrested T cells per contact, the antigen concentration plays a1508
significant role in it. The fraction of arrested T cells is highest for 4 µg/ml and lowest for 1 µg/ml1509
implying that the cells have a higher tendency to get arrested at higher antigen concentrations.1510
The conclusion that T cells have a higher probability of arrest at higher antigen concentrations1511
also supports the trend seen in (Figure 6.2a). As discussed in Section 6.3, the decrease in speed1512
values is greatest for an antigen concentration of 4 µg/ml and lowest for 1 µg/ml showing that a1513
larger number of T cells get arrested at higher concentrations. This results suggests that a larger1514
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number of arrested T cells would lead to higher number of activated T cells at higher antigen1515
concentration and thus, a higher antigen concentration would lead to a stronger T cell response.1516
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Figure 6.7: Probability of synapse formation with increasing number of kinapses
6.8 Summary1517
In this chapter, I have explored the change in T cell motion properties with time. The analysis1518
of speed and turning angle with increasing kinapses did not give enough evidence for the effect of1519
T cell signal integration on motion properties. Additionally, the probability of T cell arrest with1520
increasing number of kinapses does not vary significantly showing that there is no signal integration1521
on the level of synapses either.1522
On the other hand, I showed that T cells in the presence of higher antigen concentration have1523
a higher probability of synapse formation as compared to T cells in the presence of lower antigen1524
concentration. Interestingly, for all antigen concentrations, a majority of T cells form synapses1525
after just one kinapse.1526
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Chapter 71527
Discussion1528
7.1 Probability of Transition Analysis1529
In vivo 2-photon microscopy-based imaging of CTL-mediated immunity [111] showed that infected1530
cells need more than one contact with CTLs to get killed. But the exact impact of increasing1531
number of interactions with CTLs on probability of killing infected cells remained unknown. As1532
this finding was new and challenged the ‘one kiss-one kill’ dogma, the field critically lacked a1533
method to analyze experimental data and give a quantification of killing at the cell level. To this1534
end, I proposed the probability of transition analysis (PTA). The PTA involved extracting the1535
probability that an infected cell would get killed as a function of contact number with CTLs.1536
7.1.1 Properties of PTA1537
The PTA gives the observed probability of death at exactly the ith interaction (pobs, i). The value1538
of pobs, i is given by normalizing the number of dead infected cells with exactly i interactions by1539
the number of infected cells that have survived the ith interaction. For a system where the input1540
probability of death equals pi for the i
th interaction, the use of PTA gives:1541
pobs, i = pi (7.1)
By mathematically deriving a general expression for the probability of killed infected cells at1542
each contact, I showed that the results obtained from applying PTA are independent of other1543
properties of the experimental setup such as time and density of cells. If the value of pi was a1544
function of time, the value obtained from PTA also changed with time but this change reflects1545
how the killing dynamics of the system are changing with time. The results obtained from PTA1546
accurately reflect the killing properties of the system.1547
To further test the PTA, I used the agent-based model (ABM) together with PTA. Each1548
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hypothesis in the ABM had a hypothesis dependent killing parameter. For all hypothesis when I1549
entered different values of the killing probability, I was able to recover the value of pi, thus showing1550
the benefit of PTA.1551
I used the PTA to analyze the experimental data obtained from [111] and showed that the1552
observed probability of killing (pobs, i) infected cells linearly increased with increasing interactions1553
with CTLs. This gave us a clear insight into the dynamics of CTL mediated killing of infected1554
cells in vivo making it possible to propose different mechanisms for cell killing at the cellular level.1555
7.1.2 Versatility of PTA1556
The versatility of the PTA imply that it can be applied to a broader class of biological and1557
non-biological problems. In particular, PTA is suited for the analysis of agents undergoing an1558
irreversible change as a result of recurring events. Using PTA, we can understand the impact of1559
the recurring event (T cell meeting cells loaded with antigen) on the irreversible change (activation1560
or killing).1561
Further PTA can be used to differentiate between the signal integration hypothesis and prob-1562
abilistic priming hypothesis of T cell priming in lymph nodes [209]. The signal integration regime1563
would give rise to an increase in the value of pcalc, i with increasing i whereas the probabilistic1564
priming regime would give a constant value of pcalc, i for increasing values of i.1565
Thus, I showed that the PTA is an elegant methodology and the successful application of PTA1566
to two systems, reinforces its usefulness and versatility.1567
7.1.3 Positives and Negatives of PTA1568
The power of the PTA method is to reveal killing properties that change the observed behaviour1569
of the system with time. For a system such as infected cell contact integration, at the initial time1570
point all infected cells have had very few contacts and will therefore take more contacts to die.1571
But for the same system, analyzed from at a later time point, infected cells have had contacts with1572
CTLs and will get killed with a smaller observed number of contacts. The results obtained from1573
the PTA will reflect that and the PTA will give rise to different results at different time points.1574
But this is not an artefact of the PTA and instead shows us how the system behaviour evolves.1575
As a limitation of the PTA, it is only an analysis method that does not give a direct insight1576
into the cause behind the observed dynamics. For instance, using PTA alone, an observed increase1577
in probability of killing infected cells at increasing number of CTL contacts cannot be used to1578
conclude if the increase is caused due to change in infected cell or CTL behavior. But by designing1579
and studying an experimental setup with the number of CTLs as the limiting factor versus a system1580
with the number of infected cells as the limiting factor and making using of the PTA, it would1581
be possible to differentiate between the two possibilities. Additionally, observations taken at fixed1582
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intervals in contrast to taking observations only at the end would also be a way to distinguish1583
between hypotheses.1584
7.2 Modeling of T Lymphocyte Mediated Killing1585
The PTA showed that the probability of killing infected cell increased with increasing number of1586
interactions with CTLs. Using the understanding of the system killing dynamics from PTA, I could1587
propose various potential mechanisms that could give rise to the increase in observed probability.1588
To differentiate between the proposed mechanisms, I developed a 3-dimensional agent-based model.1589
This model was used to observe the killing patterns that emerge from various hypotheses, giving us1590
possible ways to differentiate between hypotheses. The model consisted of CTLs which moved and1591
initiated interactions with stationary infected cells in a three-dimensional space. The properties1592
of the agent-based model such as the speed and turning angle of CTLs, the positioning of infected1593
cells, the size of CTLs and infected cells were all taken from experimental data making the ABM1594
an accurate representation of the experimental system.1595
Based on the different hypothesis, CTLs made a decision to kill infected cells during the inter-1596
actions. I used the ABM to focus on the question of how to best model the CTL-mediated killing1597
and or other mechanisms that could help to better explain the observed CTL killing dynamics.1598
The results from the ABM show that by assuming an immediate removal of infected cells1599
from the system after the decision for cell death is taken, I was unable replicate the dataset1600
for observed time between the first contact to a CTL and the actual cell death for all killing1601
hypotheses. The failure to replicate the dataset led to a major result that infected cells are not1602
removed immediately from the system. Instead, they persist in the system for a certain duration1603
in a state of activated apoptosis (Tdeath) which is in agreement with previous studies [210]. Tdeath1604
is an unknown parameter that affects the results significantly. A non-zero value of Tdeath raises1605
questions about the behaviour of apoptotic infected cells. One such question is about the presence1606
of interactions between CTLs and infected cells that are in a state of activated apoptosis (zombie1607
contacts).1608
Using the agent-based model, I showed that the Null hypothesis in the absence of zombie con-1609
tacts did not give rise to an increase in probability of killing infected cells at higher interactions.1610
This is an observation that was to be expected as the Null hypothesis is a contact history in-1611
dependent killing mechanism. Instead, the absence of zombie contacts, retention of information1612
about prior contacts, by either CTLs or infected cells, might be a phenomenon that explains all1613
the observed datasets. Thus, I proposed damage-based hypotheses as potential mechanisms by1614
which the retention of contacts by infected cells is implemented. Interestingly, the hypotheses of1615
damage, saturated damage and concomitant damage and repair are not consistent, because a too1616
low damage rate was imposed by the data (Figure 3.4a) leading to a contradiction of experimental1617
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and simulated observed time between first CTL contact and cell death (Figure 3.4b). While the1618
infected cell contact integration hypothesis describes a system where the number of CTL contacts1619
determines cell death, the damage-based hypotheses also resolve the duration of the interactions,1620
i.e. a longer interaction leads to a greater damage [211–213]. The simulation results suggest that1621
the number of contacts with CTLs rather than the time integration of signals is critical for the1622
target cell fate decision.1623
Surprisingly, in the presence of zombie contacts a contact history independent killing could give1624
rise to an increase in the probability of killing infected cells with increasing interactions with CTLs.1625
This observed increase in the presence of zombie contacts raises the question if in the experimental1626
system, the killing is getting more efficient or it is an artefact of zombie contacts.1627
In addition, for all the hypotheses, a better fit with experimental data was found in the presence1628
of zombie contacts, suggesting that there is a substantial time between the decision of death and1629
actual disappearance of the cell, and that it is critical to study the behavior of cells during this1630
period. The development and use of accurate reporters to identify the apoptotic state would be a1631
useful next step. Notably, caspase activity reporter systems might be useful [214], but it is typically1632
not clear at what stage of caspase activity does the pro-cell death pathway pass an “irreversibility1633
threshold” in the context of ongoing CTL attack. Cell damage results in the initiation of Ca2+1634
signals, which trigger necrotic or apoptotic cellular death [215]. Thus, another way to know when1635
an infected cell is dying is by the use of calcium sensors. Better in vivo sensors of target cell1636
viability will be helpful to better define the “point of no return” of CTL-mediated target cell1637
killing and can subsequently help in confirmation of zombie contacts.1638
The modulation of CTL properties with increasing number of contacts with infected cells could1639
make CTLs less or more efficient. In the literature about CTL-mediated immunity against chronic1640
infections or cancer, CTL exhaustion has been described [162,163]. Exhaustion in context to CTLs1641
is usually defined as a reduced protective response in response to an ongoing antigenic activation.1642
As an example, during virus infection, it is believed that exhausted CTL lose activities like direct1643
killing and cytokine production [216, 217]. These mechanisms are in general viewed as negative1644
modulation of the killing capacity of CTLs [169]. On the level of a single cell, a CTL that has1645
interacted with multiple infected cells could become less cytotoxic. This would lead to a decrease1646
in ability to kill target cells. As expected, none of the parameter values tested indicated the1647
decreased killing of infected cells per contact (data not shown). This suggested that at the time1648
point studied and within the duration of analysis and in this experimental setting, exhaustion1649
at the time-scale of multiple contacts is not a viable hypothesis. All these results when taken1650
together show that our data is compatible with a model where CTLs could increase their killing1651
efficiency with each contact to target cells (CTL contact integration hypothesis). The CTL contact1652
integration hypothesis eventually gives rise to a diverse population of CTLs that show heterogeneity1653
during killing. This is in agreement with studies showing that CTLs have different killing properties1654
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that contribute to a robust T cell response [218,219].1655
It is important to note that the duration of contacts between alive infected cells and CTLs, and1656
zombie contacts was taken from the same distribution. At present, the data from experiments gives1657
one distribution for duration of contacts. The possibility of two distinct distribution of duration1658
of contacts can be tested through sensors to detect apoptotic phase of infected cells.1659
In general, I showed that only one dataset is not enough to discriminate hypotheses, but rather1660
their combination. For all the hypotheses, I was able to replicate the plot for observed probability1661
of killing infected cells for a certain set of parameters. If the best hypothesis had to be selected on1662
the basis of just the plot for observed probability of killing infected cells, it would not be possible.1663
These sets of parameters that were optimum for a certain plot did not necessarily give a good1664
agreement with other plots. In the rejected hypotheses, the parameter sets that are consistent1665
with one dataset are not consistent with the other one. Thus, in order to discriminate between the1666
proposed hypotheses, multiple datasets need to be analyzed.1667
I also proved that the hypotheses that work do so only for a short range of values, meaning1668
that for each successful hypothesis, the killing rates could be identified. Using a heatmap to find1669
the best parameter range, even the values of the time to die Tdeath could be identified which is1670
an important hidden biological parameter. A fascinating aspect of the estimated value of Tdeath is1671
the variation in calculated values between different hypotheses. The different values of Tdeath for1672
different hypotheses could be used to distinguish between killing mechanisms. Also, the variation1673
emphasizes the complexity of the ABM and the detail into which we can go with it.1674
The 2-photon imaging datasets shown in Figure 3.4 cannot directly identify whether the CTL-1675
mediated killing rate is constant or integrated on the CTL or infected level. However, I showed1676
here that more indicators can discriminate these remaining hypotheses. A first indicator is the1677
killing efficiency of CTLs, as defined by per capita killing rate of CTLs (PCKR) which is defined1678
as the number of infected cells killed per CTL in 24 hours [220]. The PCKR values obtained1679
for the final hypotheses are different for varying number of initial CTLs and infected cells. The1680
varying values of PKCR as a function of cell density suggest that a careful measurement of PKCR1681
values for different cell numbers is suitable to discriminate the hypotheses. It is also surprising1682
to note that even at very low number of infected cells, the CTLs still fail to kill all infected cells1683
which contradicts the rapid CTL mediated killing seen in other studies [192]. This could be a1684
consequence of random cell movement and raises the question whether directed cell movement1685
where CTLs actively migrate towards infected cells is important to ensure successful elimination1686
of more infected cells.1687
In [111], the PCKR values were found to range from 2 to 16. It is interesting that with our1688
model, the hypothesis that gives the values most consistent with this range is the Null hypothesis in1689
the presence of zombie contacts but this information isn’t enough to reject the other hypotheses.1690
The significance of cytotoxicity mediated by CTLs and the impact of the number of cells on1691
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PCKR and fraction of killed infected cells are especially important due to the role of T cells in1692
viral infections such as HIV, pneumonia and other diseases such as cancer [175,221].1693
The fraction of total killed infected cells shows a linear increase with increasing number of1694
CTLs, implying that CTL mediated killing follows mass action killing kinetics. Previous studies1695
have shown that T cells show mass action killing kinetics in the spleen [197] and our results suggest1696
a similar dynamic in the lymph node.1697
A recent study [222] reported a higher PCKR value at low CTL to infected cell ratio. In1698
the simulations, we observe a similar behaviour when we vary the number of infected cells while1699
keeping the number of CTLs constant (Figure 4.6b). But it was not in agreement with the results1700
obtained when keeping the number of infected cells constant and varying the number of CTLs.1701
Thus, our results suggest that instead of the ratio of CTLs to infected cells, the number of infected1702
cells impact the PCKR values.1703
7.3 Limitation of Experimental Values1704
The experimental values used to discriminate between hypothesis gave us a detailed insight into the1705
dynamics of the lymph node. But due to the complexity and length of the experiments, the sample1706
size for all datasets was relatively small. The dataset for observed probability of killing infected1707
cells had values for up to 14 CTL contacts. The number of cells which had 7 or more contacts with1708
CTLs were just 3. Thus, I discarded these data points as they are not statistically significant. The1709
limitation of rejecting these data points is that I could not discriminate between two hypothesis1710
that were behaving similarly for smaller number of contacts and had different behavior for higher1711
number of contacts.1712
In the experimental setup, CTLs exit and enter the area under observation. This implies that1713
the history of all CTLs under observation is not known. This property of the experimental system1714
makes it difficult to draw conclusions about the CTL behavior based on prior contacts. In the1715
ABM, I have assumed that CTLs that leave from one side enter from the other making it possible1716
to keep track of CTL history.1717
7.4 Comments on Model1718
7.4.1 Agent Based Modeling in Retrospect1719
The ABM developed in this study achieves a good level of accuracy without compromising on its1720
simplicity. Including the speed, turning angle and duration of contact from experimental data1721
makes the model similar in behaviour to an actual lymph node. Further, the inclusion of these1722
values from experimental data accounts for the impact of other cells in the lymph node.1723
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The reason for choosing the agent-based modeling technique was to zoom into the properties of1724
the system that cannot otherwise be observed due to its bottom up approach [205]. These include1725
things such as the killing mechanism, the value of Tdeath and the presence of zombie contacts.1726
While other approaches to study CTL mediated killing such as differential equations and chemical1727
kinetics have been employed extensively, the complexities that can be incorporated using the ABM1728
gives cannot be done easily from other modeling approaches. An example of this would be to model1729
the spatial heterogeneity of the system. With ABM, it is much easier to implement a heterogeneous1730
space while EBMs work well for a homogeneous population. In the ABM developed in this study1731
too, the infected cells are not distributed uniformly throughout the space and the implementation1732
of this property was simple.1733
For the system described above, the other option would be to have an equation-based model1734
(EBM). EBM employs a set of equations to describe the properties of the system. Ordinary and1735
partial differential equations are two examples of this approach. The shortcoming of EBM in1736
comparison to ABM is that it can only be used to model output with real system behavior on a1737
systems level but the behavior of individual units cannot be validated [223, 224]. On the other1738
hand, ABMs focus on the individual behavior of the components, thereby offering an additional1739
layer of validation. This is also seen in the ABM of the lymph node, where all agents behave1740
independently allowing for a greater variation between cell behavior, thus, making it more like an1741
in vivo system.1742
The change in emergent phenomena by changing a single detail regarding zombie contacts1743
highlights how agent-based modeling approach allows us to implement features in this model with1744
an ease that would not be possible in other modeling pathways. While a similar model could be1745
implemented by employing ordinary differential equations (ODEs) and partial differential equations1746
(PDEs), it would be involve the addition of assumptions to reach a level of complexity that ABM1747
does naturally.1748
For each of the hypotheses, I estimated the best parameter sets. These parameter set could be1749
used to make predictions about previously unexplored system readouts such as PCKR and fraction1750
of killed cells. An experimental setup to explore these values would span over months, if not years.1751
In contrast, the ease and speed of the ABM makes it an ideal setup to explore system details in a1752
short duration of time.1753
7.4.2 Limitations of Model1754
The ABM that I have developed is a representation of a lymph node. Yet, it includes just two1755
types of cells- CTLs and infected cells. It is important to note that I have not yet included cells1756
other than infected cells that might be able to interact with CTLs by processing and presenting1757
extracellular antigens with MHC class I molecules to them. The speed, turning angle and duration1758
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of contacts have been taken from experimental data. These values come from a system that has1759
many other cell types. Thus, they already include the impact of other cells on this value. By1760
including the experimental values in the system, I have also accounted for other cells but any other1761
impact of the cells which have not been included remains unaccounted for.1762
While the model I have developed is an extremely versatile tool but a limitation of the estimated1763
parameters obtained from the agent-based model is that they fit best for a specific system that1764
describes an in vivo setup. As established with the PCKR and fraction of killed infected cell1765
analyses, the results differ based on initial number of infected cells and CTLs. Thus, the parameters1766
identified in the paper hold true for a certain experimental set-up and cannot be taken for different1767
initial conditions. But the benefit of the model is the ease with which it can be adapted to various1768
other initial conditions. Consequently, while the agent-based system described in the paper is for1769
an in vivo system, it can be applied to different setting by varying the parameters. It can be used1770
to study the killing mechanisms under different conditions.1771
7.5 Temporal Bias in Experimental Observations1772
The application of PTA on the results obtained from the ABM showed that a variable observation1773
window gives rise to a variation in results for systems that evolve with time. On the other hand,1774
the analysis results remain the same for systems with no change in dynamics over time, such as1775
the contact history independent killing mechanism. This indicates the importance for observing1776
experimental systems for the same duration as a comparison between the dynamics of two differ-1777
ent systems could give the same observed results if observed at different duration giving rise to1778
erroneous conclusions.1779
Similarly, observing the experimental setup after a certain time has elapsed gave rise to a1780
history of cells that remains unobserved and unaccounted for. This too, gave a variation in results1781
for systems that were changing with time. This suggests that while planning experiments where1782
it is unknown if the system is evolving with time, it is imperative to ensure that the observations1783
are being taken at a fixed time after initiation.1784
All these results together make a strong case for uniformity in experimental observations with1785
respect to time. The observation duration for all experiments that are to be compared should be1786
kept constant and the observation should be initiated after a fixed time.1787
7.6 Thoughts on T cell Activation1788
T cell activation has been shown to require an arrest on an APC [114]. Prior to this arrest, T1789
cells move around the network of APC, alternating between a kinapse mode that occurs when the1790
T cell has transient interactions with APCs and a searching mode that occurs when T cells move1791
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around looking for APCs [99]. Further, it has been hypothesized that T cells integrate signals from1792
APCs in order to get activated [101,225]. A study has also shown that the T cell and APC synapse1793
can be broken and formed multiple times and this has the same effect on T cell proliferation as a1794
long-lasting contact [118].1795
In the study by Mayya et al. [207], they used a 2D stimulatory surfaces with uniformly coated1796
antigen at equidistant, uniform spots to study T cell motion and interaction with antigen spots. In1797
a set of analysis, I explored the hypothesis of signal integration on T cell motility. The proposed1798
hypothesis that I was exploring was that T cells change their motion properties as a consequence of1799
signal integration. I analyzed the cell tracks to obtain the speed and turning angle values for time1800
blocks of 20 minutes. The motion properties did not show any change with an increasing time.1801
Since signal integration is a consequence of kinapses with antigen spots, I also computed the speed1802
and turning angle in the kinapse mode and the searching mode as functions of the total number1803
of kinapses that the T cell has had. For this analysis too, the motion properties remained largely1804
unchanged. The results from the analysis did not provide enough evidence for a signal integration1805
at the motility level in contrast to prior studies [226].1806
T cell get arrested on APCs after forming kinapses with antigen spots. Here, I also considered1807
the effect of signal integration on T cell arrest. I studied the impact of increasing number of1808
kinapses on T cell arrest using the PTA. Surprisingly, the probability of T cell arrest remained1809
largely unchanged with increasing number of kinapses. But it is interesting to note that the1810
probability of cell arrest was higher at higher antigen concentrations in accordance with previous1811
studies [102, 227]. The fewer number of kinapses needed for permanent arrest at a higher antigen1812
concentration suggests that T cells activation is dependent on antigen concentration. However,1813
the probability of arrest with increasing number of kinapses computed using PTA suggests that1814
there is no signal integration. Thus, while the effect of signal integration on the motion properties1815
cannot be confirmed, the effect of signal integration on synapse formation is absent.1816
7.7 Future Perspectives1817
By making use of simple and universal properties of cells, the ABM described in this study encap-1818
sulates a system that is observed very commonly. Despite being defined by such basic properties,1819
this system has the ability to estimate the behavior at a cellular level while on the other hand, it1820
can also be used to predict emergent phenomena. With an increase in knowledge in the field, the1821
properties of the agents could easily be updated thereby making the system more powerful and1822
accurate. Due to the versatility and efficiency of the ABM, it can be used to expand our knowledge1823
in various ways:1824
1. In ABM described above, it would be interesting to introduce calcium signaling and flux in1825
the infected cells as a consequence of interaction with CTLs [111]. This could then be used1826
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to study the heterogeneity in calcium signaling after single CTL contacts.1827
2. An interesting addition to the system would be introduction of varying affinities of T cells1828
and infected cells with each other [228]. This would make the model more like an actual1829
biological system and would help explore the mechanism of eliminating infected cells in a1830
realistic setup.1831
3. The inclusion of other types of cells into the system would make the ABM more malleable.1832
By making a general framework of a system with more cells, this model could then be used1833
to study other in vivo and in vitro systems.1834
4. A more ambitious direction for the model involves the introduction of defense mechanisms1835
by target cells. Melanoma cells have been shown to secrete enzymes that degrade perforin1836
[229] whereas certain virus-infected cells have been shown to escape CTL detection by the1837
expression of viral immune evasion proteins [230, 231]. The dynamic interplay that arises1838
between CTLs and target cells would be a fascinating topic to study.1839
7.8 Final Statements1840
In 1984, G. J. V. Nossal [232] wrote “A readership consisting of primarily anatomists has every right1841
to question the favorite sport of research workers in cell immunology. This is to take a lymphoid1842
tissue and totally destroy its beautiful and elaborately designed architecture to obtain simple cell1843
suspension of lymphocytes, which are then asked to do more or less all the jobs of the original1844
anatomic masterpiece.” With the wide use of in silico techniques today, computational biologists1845
in the field of immunology have the same favorite sport as research workers in cell immunology.1846
While the recreation of a lymphoid tissue using simple rules might seem like a step down, it is1847
imperative to understand that even by employing simple rules, scientists have gained remarkable1848
insight into the workings of a lymphoid tissue. Moreover, it is by using the insights gained from1849
these systems as building blocks, that we can hope to have a complete understanding of the elegant1850
workings of the immune system.1851
With this study, I have tried to further our knowledge of the lymph node by designing a simple1852
ABM of CTL mediated killing of infected cells. By means of the ABM, I have proposed potential1853
mechanisms that CTLs could employ to kill infected cells. Additionally, I have provided a way to1854
quantify the impact of increasing number of contacts with CTLs on infected cell death. With the1855
understanding that we obtain from PTA, we are one step closer to understanding how CTLs kill1856
infected cells and how T cells are activated.1857
The importance of T cells as a part of the immune system cannot be stated enough. They play1858
multiple roles in the adaptive immune system which include but are not limited to recognizing1859
and killing antigens and infected cells, acting as helper cell to interact with B cells and acting as1860
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regulatory cells to diminish the immune response. A deficiency in T cells can manifest as blood1861
disorders, digestive problems and autoimmune disorders to name a few. Additionally, due to the1862
function of killing infected cells, the use of T cells as a part of immunotherapy against cancer and1863
chronic infectious diseases has confounded and intrigued scientists for over a century now [233].1864
In a field as dynamic as this, our knowledge is increasing in leaps and bounds and a clearer un-1865
derstanding of T cell killing and activation mechanisms will play an indispensable role in designing1866
better immunotherapies. I hope that this study will help in pushing the envelope a little further1867
in the field.1868
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